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 Monitoring pressure in organ systems such as the brain, eye, and blood vessels form an 
essential diagnostic basis for assessment of patient health and progression of diseases such as 
traumatic brain injury, hydrocephalus, glaucoma, and hypertension. Conventional sensor 
technologies designed for precise, continuous monitoring of pressure are available in the form of 
accurate, implantable devices that must be surgically extracted after use, the procedures of which 
are costly and can expose the patient to significant pain and risks for complications. These 
permanent electronic hardware may also act as a nidus for infection, via biofilm formation along 
percutaneous wires, and provoke immune-mediated inflammatory responses. Here, we report 
materials, device structures, and fabrication strategies for bioresorbable pressure sensors, in 
which all of the constituent materials dissolve in biofluids over well-defined periods of time, 
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Bioresorbable, Implantable Devices 
A defining characteristic of modern silicon electronics is its ability to remain physically 
invariant almost indefinitely. An emerging class of technology known as ‘transient electronics’ 
demonstrates the opposite behavior; here, all of the components completely disappear at 
prescribed times and controlled rates when exposed to water or biofluids1-10. Fabrication of such 
devices involve biodegradable electronic materials such as nanomembranes of monocrystalline 
silicon (semiconductors), magnesium (metals), and silicon dioxide (insulators) and polymers 
such as poly(lactic-co-glycolic acid) (PLGA; device substrates), the degradation of which yield 
biocompatible end products. Recently published examples of transient electronics include 
circuits3, radios9, and power supply systems3,10 for physical sensors of pressure, temperature, 
flow rate, and motion6, chemical sensors1,6, thermal actuators3,9, and controlled drug-delivery 
vehicles1,7 for use in areas of the body such as the intracranial space, abdominal cavity, 
intramuscular regions of the lower extremity, and subdermal implantation at the dorsolateral 
area3,6,8.  
The transient behavior of these devices enables potential application possibilities that 
cannot be addressed with conventional electronics. Examples include environmental sensors that 
dissolve via exposure to moisture over time to eliminate the need for recovery, consumer 
electronic devices that naturally decompose to minimize costs and health risk associated with 
recycling and management of waste streams, and implantable diagnostic and therapeutic devices  
that naturally resorb (i.e. become disintegrated, then absorbed) in the body after clinically useful 
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timeframes to minimize costs and risks of complications associated with surgical extraction 
procedures.  
Bioresorbable, implantable devices capable of active sensing, electronic processing, 
communication and/or actuation within the body are of particular interest, as they represent an 
unaddressed technological opportunity in which they can, in some cases, replace conventional 
technologies only available in the form of permanent hardware, such as deep brain electrical 
stimulators11, cardiac pacemakers12, programmable drug delivery systems13, and pressure 
monitoring systems14, as examples. The devices may operate for some finite periods of time, as 
defined by management and healing process of a disease, after which they resorb to eliminate 
unnecessary device load to avoid surgical extraction.  
 
Intracranial Pressure Monitoring 
Monitoring of pressures in various organ systems in the body such as the brain14, eye15, 
blood vessels, abdomen16, and bladder17 have proven clinical utility in diagnosis and 
management of traumatic brain injury, glaucoma, hypertension, abdominal compartment 
syndrome, and neurogenic bladder hypertension, respectively. Among these, intracranial 
pressure (ICP) monitoring is of particular interest due to the clinical impact of traumatic brain 
injury (TBI). Defined as sudden damage to the brain caused by a blow or jolt to the head, 
commonly caused by car or motorcycle crashes, sports injuries, and assaults, TBI is the leading 
cause of death and disability among people aged 1 to 44, responsible for the death and 
hospitalization of 50,000 and 235,000 Americans respectively every year11.  
Clinicians typically employ ICP monitoring techniques throughout clinical, surgical, and 
rehabilitation steps for patients with severe TBI18. Capabilities in precise, continuous monitoring 
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of pressure by invasive monitoring techniques using implantable biomedical devices can, 
therefore, be critically important in defining treatment protocols that decrease the rate of 
morbidity and increase the pace of recovery15,19,20. Conventional, standard permanent electronic 
hardware, however, acts as a nidus for infection: bacteria form biofilms along percutaneous 
wires, or seed haematogenously, with the potential to migrate within the body and to provoke 
immune-mediated pathological tissue reactions21,22. The associated surgical retrieval procedures, 
meanwhile, subject patients to the distress associated with re-operation and expose them to 
additional complications23. Electronic devices that naturally resorb/dissolve in biofluids provide 
the ultimate solution to these problems, thus motivating the research on bioresorbable pressure 
monitors.  
 
Overview of Thesis 
Chapter 1 describes recent study on bioresorbable implantable silicon sensors for 
monitoring ICP, with wireless data and power communication capabilities in both fully and 
partially implantable platforms. In vitro hydrolysis studies demonstrate complete disappearance 
of the device structures over time in simulated biofluids. In vivo demonstrations in rats illustrate 
capability to continuously monitor ICP up to 3 days.  
Chapter 2 describes unpublished (recently submitted) work on bioresorbable ICP 
monitors with thermally-grown silicon dioxide biofluid barriers with improved stable operation 
lifetime, capable of operation in biofluids up to 25 days. In vivo analyses of biodistribution of 
dissolved silicon, hematology (complete blood count), blood chemistry, and histology 
demonstrate nontoxicity and biodegradability of the sensor. 
4 
 
Chapter 3 describes recent work on bioresorbable, Fabry-Perot ICP sensors 
interconnected with optical fibers to enable fully optics-based operation, eliminating issues of 
current leakage or magnetic resonance compatibility associated with electronic sensor implants. 
In vitro hydrolysis study results demonstrate biodegradability of these platforms. Data on in vitro 
and in vivo ICP measurements illustrate their accuracy.  
Chapter 4 provides perspectives on bioresorbable device technologies, with details about 
on-going studies regarding biopolymer optical fibers that may go along with optical ICP sensors 
in Chapter 3 for fully bioresorbable optical platforms.  
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CHAPTER 1: BIORESORBABLE SILICON SENSORS FOR THE BRAIN 
 
1.1 Introduction 
Many procedures in modern clinical medicine rely on the use of electronic implants in 
treating conditions that range from acute coronary events to traumatic injury1,2. However, 
standard permanent electronic hardware acts as a nidus for infection: bacteria form biofilms 
along percutaneous wires, or seed haematogenously, with the potential to migrate within the 
body and to provoke immune-mediated pathological tissue reactions3,4. The associated surgical 
retrieval procedures, meanwhile, subject patients to the distress associated with re-operation and 
expose them to additional complications5–8. Here, we report materials, device architectures, 
integration strategies, and in vivo demonstrations in rats of implantable, multifunctional silicon 
sensors for the brain, for which all of the constituent materials naturally resorb via hydrolysis 
and/or metabolic action9–12, eliminating the need for extraction. Continuous monitoring of 
intracranial pressure and temperature illustrates functionality essential to the treatment of 
traumatic brain injury2,13; the measurement performance of our resorbable devices compares 
favourably with that of non-resorbable clinical standards. In our experiments, insulated 
percutaneous wires connect to an externally mounted, miniaturized wireless potentiostat for data 
transmission. In a separate set-up, we connect a sensor to an implanted (but only partially 
resorbable) data-communication system, proving the principle that there is no need for any 
percutaneous wiring. The devices can be adapted to sense fluid flow, motion, pH or thermal 
characteristics, in formats that are compatible with the body’s abdomen and extremities, as well 
S.-K. Kang, R.K.J. Murphy, S.-W. Hwang, S.M. Lee, D.V. Harburg, N.A. Krueger, J. Shin, P. Gamble, H. Cheng, 
S. Yu, Z. Liu, J.G. McCall, M. Stephen, H. Ying, J. Kim, G. Park, R.C. Webb, C.H. Lee, S. Chung, D.S. Wie, A.D. 
Gujar, B. Vemulapalli, A.H. Kim, K.-M. Lee, J. Cheng, Y. Huang, S.H. Lee, P.V. Braun, W.Z. Ray and J.A. 
Rogers, "Bioresorbable Silicon Electronic Sensors for the Brain," Nature 530, 71-76 (2016). Reprinted with 
permission from NPG. 
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as the deep brain, suggesting that the sensors might meet many needs in clinical medicine. 
 
1.2 Experiments 
 Fabrication of bioresorbable silicon pressure sensor began with solid-state diffusion of 
boron at 950oC of a silicon-on-insulator wafer (SOI; top Si ~ 300 nm, buried SiO2 ~1 μm, Si 
wafer ~ 600 μm; SOITEC, France) to obtain doped p-type silicon. Patterning with an array of 
holes (diameter ~3 μm, distance between holes ~30 μm), reactive ion etching (Plasma-Therm 
RIE; 50 mTorr, 100 W, 40 sccm SF6) to etch holes through the Si NM and expose buried SiO2, 
and immersing the wafer in hydrofluoric acid removed the buried oxide and allowed transfer of 
the Si NM onto a bilayer of diluted polyimdie (poly(poly(pyromellitic dianhydride-co-4,4′-
oxydianiline)), ~300 nm)/PMMA (poly(methyl methacrylate), ~300 nm) on a temporary silicon 
carrier substrates.  
Photolithography and RIE process patterned the Si NM into serpentine elements. 
Electron-beam (e-beam) evaporation, patterning, and wet etching in buffered oxide etchant 
formed a thin film of SiO2 (~100 nm) for electrical passivation. Spin-coating a layer of D-PI 
(~300 nm), curing in an oven at ~200oC for an hour, patterning and dry etching (March RIE; 200 
mTorr, 150 W, 20 sccm O2) etched through all of the layers (D-PI/SiO2/D-PI/PMMA), which 
could then be immersed in a warm bath of acetone (~50oC) to dissolve the PMMA sacrificial 
layer and release the individual serpentine Si NM elements sandwiched between layers of D-PI. 
D-PI was removed by March RIE first while the device was on the poly(dimethylsiloxane) 
(PDMS) stamp during transfer, then again after device was transferred on a biopolymer film of 
poly(lactic-co-glycolic acid) (PLGA, ~30 μm).  
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 Fabrication of nano-porous silicon (np-Si, ~80 μm thick) substrate involved double-side 
polished, highly doped p-type Si wafers at current density of 160 mA cm-2, as reported 
previously1. Careful transfer of released np-Si to a glass wafer spin-coated with a thin film of 
PDMS allowed microfabrication processes to be carried out without damaging the np-Si. 
Fabrication of trench (i.e. square regions of etched relief of dimensions 2.5 mm x 2.5 mm x 40 
μm) on the np-Si substrate involved deposition of ~300 nm-thick film of PECVD (plasma-
enhanced chemical vapor deposition) SiO2 mask, patterning and wet etching using BOE, dry 
etching using RIE, and removing the oxide mask by wet etching. Fabrication of magnesium 
trench structures involved patterning and wet etching Mg foil (~100 μm thick, Goodfellow, 
USA) in a mixture of acetic acid (CH3COOH, Transene Company Inc., USA) and deionized (DI) 
water (20 ml : 250 ml), stirred using a magnetic bar, until trench is ~40 um deep, followed by 
aligned laser cutting to define outer dimensions of the substrate (rectangular or pointed-end 
designs). Final step of fabrication involved transferring the PLGA films with Si NM elements 
onto the np-Si or Mg trench structures, heating the samples near glass transition temperature of 
PLGA (~65 oC) to bond the PLGA to the substrate and form a sealed air cavity.  
 
1.3 Results and Discussion 
Figures 1.1a and 1.2 show a bioresorbable pressure sensor with a magnified illustration of 
the active region and its cross-sectional side view. The construction involves a membrane of 
poly(lactic-co-glycolic acid) (PLGA, with a thickness of 30 μm), sealed against a supporting 
substrate of nanoporous silicon (60-80 μm thick; 71% porosity) or magnesium foil (60–80 μm 
thick; see Figs 1.3, 1.4). The substrate has a square structure of relief (with a depth of 30–40 μm) 
etched onto its surface. The associated air cavity allows the membrane to deflect in response to 
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pressure in the fluid surroundings. A silicon nanomembrane in a serpentine geometry serves as a 
piezoresistive element that rests on the surface of the membrane near one of the edges of the 
cavity, where deflection- induced strains are largest (Fig. 1.1b). The resistance of this sensing 
element increases monotonically in a linear fashion across the full range of pressures that are 
relevant to intracranial monitoring (that is, 0–70 mm Hg). An overcoat of silicon oxide (SiO2, 
about 100 nm thick) provides electrical passivation and a barrier against biofluids. Figures 1.1c 
and 1.5 show photographs of two representative devices of different dimensions to illustrate the 
scalability of fabrication; the total sizes and weights are 1 mm × 2 mm × 0.08 mm (trench size: 
0.67 mm × 0.8 mm × 0.03 mm) and about 0.4 mg; and 3 mm × 6 mm × 0.11 mm (trench size: 2 
mm × 2.4 mm × 0.04 mm) and roughly 1 mg, respectively. The mechanics of the system can be 
captured quantitatively by three-dimensional finite element analysis (FEA). Distributions of 
principal strains and vertical displacements evaluated at an external pressure of 50 mm Hg 
appear in Figure 1.1d. The maximum strain for any applied pressure over the range of interest 
occurs at the midpoint of the left (and right) edge of the trench, thus motivating this choice of 
location for the silicon-nanomembrane piezoresistive element (see Methods and Figures 1.6 and 
1.7 for details)14. The calibration between pressure and resistance is linear, with a slope of 83 
Ω/mmHg), consistent with modelling results and a gauge factor of about 30, which lies within a 
range of expected values for monocrystalline silicon (Fig. 1.8)15.  
Evaluations in set-ups that resemble the intracranial cavity reveal measured pressure 
responses that agree quantitatively with those of clinical- standard, non-bioresorbable sensors 
(Figs. 1.1e and 1.9-1.11). With various simple modifications, this same platform can be used for 
precision measurement of other parameters of interest in biomedicine and clinical care. 
Examples include: motion sensors built with a cantilevered test mass of PLGA (that is, a single-
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axis accelerometer, Fig. 1.1f); temperature sensors that exploit the temperaturedependent 
resistance of silicon-nanomembrane elements set apart from the cavity structure (Fig. 1.1g); flow 
sensors in which the silicon nanomembranes serve simultaneously as heating elements and 
temperature sensors (Fig. 1.1h); thermal conductivity/diffusivity sensors that exploit related 
concepts (Fig. 1.1i); and pH sensors that rely on electrostatic gating of transport through the 
silicon nanomembrane (Fig. 1.1j). In addition, chemically functionalizing the surface of the 
silicon of this last device provides a route to biomolecular sensing, using schemes similar to 
those in conventional silicon biosensors16–18. The fabrication methods and operating principles 
for each of the modalities in Fig. 1.1f–j appear in Methods and Figures 1.12-1.16.  
The uniqueness of these devices is their ability to dissolve completely into biocompatible 
end products when immersed in aqueous solutions, including biofluids such as cerebrospinal 
fluid (CSF). Hydrolysis of the silicon nanomembranes, the layers of SiO2, the thin wafers of 
nanoporous silicon and the magnesium foils causes loss of material at rates of 23 nm day−1, 8 nm 
day−1, 9 μm day−1 and 4 μm day−1, respectively, in artificial CSF (ACSF) at physiological 
temperature (37 °C) (Fig. 1.17). Separate studies indicate that PLGA (75:25 (lactide:glycolide) 
composition) dissolves in biofluids within four to five weeks19. To illustrate the various stages of 
dissolution of a completed system, Fig. 1k shows a sequence of images of a bioresorbable 
pressure sensor inserted into a transparent cha zber designed for accelerated testing 
(polydimethylsiloxane (PDMS) enclosure filled with buffer solution at pH 12 and room 
temperature), in which fluid exchange can occur through an array of openings around the 
perimeter (Fig. 1.18). Figure 1.19 presents images of nanoporous silicon and silicon 
nanomembranes observed by scanning electron microscopy at different times during hydrolysis. 
The silicon nanomembrane dissolves uniformly, without fracture. By comparison, nanoporous 
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silicon dissolves less uniformly, with a tendency to form fragments. Here, the silicon-
nanomembrane and SiO2 components dissolve first, within 15 hours, followed by the nanoporous 
silicon, which disappears within 30 hours. In all cases, the dissolution kinetics depends strongly 
on the materials and the composition of the surrounding solution20–22. Table 1.1 summarizes the 
hydrolysis mechanisms and dissolution rates of these materials in a representative solution. As 
described below, the encapsulation material and its thickness define the operational lifetimes.  
Figure 1.20 illustrates a strategy for using these types of bioresorbable systems for 
wireless pressure and temperature monitoring in the intracranial space of rats. Figure 1.20a 
shows a photograph of a device like the one in Fig. 1.1c, but configured to allow simultaneous 
sensing of both pressure and temperature. The measured temperature can also be used to 
calibrate against parasitic effects of this parameter on the pressure determination (see Methods 
and Fig. 1.21). Biodegradable molybdenum wires (10 μm thick) serve as an interface to wireless 
communication systems. Pressing the interconnect wires (molybdenum, 10 μm thick, or 
magnesium, 50 μm thick) against the PLGA at elevated temperatures (65 °C) embeds them near 
the surface but leaves the top regions exposed, thereby allowing for deposition of biodegradable 
metals (molybdenum, 2 μm thick) to form electrical contact pads through stencil masks (made 
from the polyimide Kapton, 12.5 μm thick; Fig. 1.22). The deposited molybdenum forms stable 
interconnects between metal wires and silicon nanomembranes that are fully embedded on 
PLGA. Encapsulation with a bioresorbable polymer (polyanhydride, discussed in more detail 
below) enhances system robustness by reducing the stress concentrations at the interconnections. 
Narrow strips of PLGA laminated onto the front and back sides of the wires along their entire 
lengths act as electrical insulation. These insulated wires connect to an externally mounted, 
miniaturized wireless potentiostat for transmission of data thorough percutaneous wiring.  
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Figure 1.20b provides a diagram of such a system in the intracranial space of a rat model. 
The sensor subsystem connects via molybdenum wires to the wireless module, which is mounted 
on the top of the skull. Figure 1.20c–e summarizes the surgical process. A PLGA sheet (about 80 
μm thick) and a dissolvable surgical glue (Fig. 1.20c) seal the craniectomy defect to close the 
intracranial cavity. Conventional sutures hold the surgical site closed, in a standard process23 that 
retains points at which the dissolvable wires emerge from the skin to allow electrical connection 
(Fig. 1.20d). These wires have dimensions comparable to those of the surgical threads, and 
therefore pose little additional risk. Figure 1.20e shows a healthy, freely moving rat with a 
complete system. Figure 1.23 presents image of the connections.  
Figure 1.24 summarizes the results of a comprehensive set of wireless measurements of 
intracranial pressure (ICP) and intracranial temperature (ICT), recorded in rats with percutaneous 
wired systems. The ICP traces reveal features that correspond to periodic manual abdominal 
compression activating the Valsalva manoeuvre, which yields rapid increases or decreases in ICP 
(Fig. 1.24a)24. Gentle changes in the rat’s position—that is, Trendelenburg (30° head-down 
position) and reverse Trendelenburg (30° head-up position)—produce gradual increases and 
decreases in ICP, respectively (Fig. 1.24b), as would be expected because of the corresponding 
accumulation and depletion of blood in the brain25. The pressure values compare well with those 
determined using a clinical-standard, wired ICP sensor implanted in the same region of the same 
animal.  
The wireless, bioresorbable ICT sensors perform to levels of accuracy similar to those of 
commercial sensors: Figs. 1.24c and d show comparative data collected by modulating the 
cranial temperature with a heating or cooling blanket placed beneath the animal. The operational 
lifetimes of the devices are defined by dissolution of the encapsulation layers and the permeation 
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of fluids through them. In vitro experiments using a bioresorbable pressure sensor encapsulated 
with a film of a specially synthesized polyanhydride (about 120 μm thick; Fig. 1.25) show 
expected performance and accurate readings with an appropriately modified calibration factor 
(50 Ω/mmHg). The slow dissolution rate of the polyanhydride (about 1.3 μm day−1)—together 
with the modest change in sensitivity that occurs depending on the thickness of this material 
(about 0.34 Ω(mmHg)−1 μm−1)—leads to a loss of accuracy of only a few per cent when operated 
over several days. This error falls within standards defined by the Association for the 
Advancement of Medical Instrumentation (AAMI) for pressure monitoring, that is, ±2 mm Hg 
(from 0 to 20 mm Hg) and ±10% (from 20 to 100 mm Hg)2. (Methods and Figs. 1.26-28 present 
information on the synthesis/hydrolysis chemistry, dissolution kinetics, water permeability, and 
biocompatibility of the polyanhydride.) Stable, continuous operation is possible for up to three 
days (Fig. 1.29). Beyond this period, water tends to pass through the polyanhydride and PLGA 
into the electrically active regions of the device and the air cavity. The resistance remains 
relatively constant for seven days, and then begins to increase markedly, mainly because of 
dissolution of the molybdenum wires and interconnection metal (Figs 1.30 and 1.31). Figure 
1.24e illustrates in vivo operation for three days without notable degradation in absolute accuracy 
or sensitivity, as benchmarked against a standard, non-resorbable wired sensor. Figure 1.32 
shows similar data from the temperature sensor, where the absence of an air cavity affords 
enhanced stability, and accurate measurements for six days of operation. These timeframes are 
relevant for clinical use: ICP and ICT are typically monitored continuously for several days after 
traumatic brain injury. The chemistry, thickness and composition of the encapsulating layers can 
be selected to extend the functional lifetimes26.  
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Biocompatibility of the devices through all stages of their life cycle is essential. 
Comprehensive studies of the immunohistochemistry of brain tissues at several times after 
implantation (two, four and eight weeks) demonstrate that the sensors and the by-products of 
their dissolution in the intracranial space are biocompatible. Representative confocal 
fluorescence images (see Fig. 1.24f for nanoporous silicon and Fig. 1.33 for magnesium foil) 
indicate no overt reaction of brain glial cells to the sensor, and no focal aggregation of glial cells 
at the implantation site for all time ranges. Astrocytosis (an increase in the number of astrocyte 
cells) and microglial activity at the cortical surface are within normal limits, indicating no overt 
immune reaction to the device and its by-products.  
Although the percutaneous wiring does not noticeably affect animal behaviour (see 
Methods and Fig. 1.34), a miniaturized, fully implantable wireless communication system might 
offer advantages, by removing the possibility of secondary infection at the wires. A wireless 
system constructed mostly, but not entirely, of resorbable materials (~85% by mass and ~86% by 
volume)—using an advanced near-field communication-technology approach, with fully 
bioresorbable metal coils, substrates and encapsulation layers—appears in Figure 1.35, Methods, 
and Figures 1.36-1.41. Given that these devices function successfully in the intracranial space, 
they could also be used in other organs and body compartments. As an example, Fig. 1.42a and b 
illustrate ICP monitoring using the same bioresorbable device in modes with relevance to acute 
abdominal compartment syndrome and acute compartment syndrome of the extremity27,28. 
Furthermore, modifying the devices to allow them to be injected deep into tissues could address 
other needs in clinical treatment. For example, monitoring physiological parameters of the deep 
brain with intraparenchymal sensors could yield data that are unavailable from the surface or the 
intracranial space. In addition, because electrophysiological and metabolic abnormalities often 
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emanate from infarcts, contusions and haematomas that damage adjacent intact tissue, sensors of 
pressure, temperature, pH and other physical/chemical parameters that are placed into the 
parenchyma within the blood-deprived (ischaemic) penumbra could advance our knowledge of 
secondary brain injury29–31. Such considerations apply not only to injured brain tissue, but also to 
acute or chronic ischaemia that threatens the heart, limbs, intra-abdominal organs or grafts.  
Modifying the geometry of the supporting structures introduced in Figure 1.1 enables 
delivery of bioresorbable sensors into the depths of brain tissue, for direct measurements of 
injury or status. Figure 1.42c shows an example that integrates a bioresorbable ICP sensor onto a 
magnesium foil, formed with a tip region that allows injection into tissues of interest (Fig. 1.43). 
Mounting the device on a stereotactic frame and fixture allows accurate positioning and 
controlled penetration (Fig. 1.44). Figures 1.42d and e summarize pressure and temperature data 
collected at a site about 5 mm beneath the surface of the rat brain. The Valsalva manoeuvre 
yields data that quantitatively agree with those obtained using conventional sensors at a similar 
location. The device detected changes in temperature during anaesthesia (the temperature 
decreased, owing to reduced blood circulation) and waking up (the temperature returned to 
normal), as expected of intraparenchymal tissue.  
 
1.4 Conclusion 
The biomedical sensors reported here enable wireless data collection in body cavities and 
in deep tissues, with platforms that are fully bioresorbable, thereby allowing patients to be 
monitored until homeostasis has been achieved, and avoiding the risks associated with 
chronically implanted devices or their removal32,33. In vivo and in vitro experiments demonstrate 
precision measurements of pressure, temperature, motion, flow, thermal properties and pH, with 
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possible extensions to biomolecular binding events. These features will be useful in diagnosing 
and treating a diverse range of medical conditions, from acute traumatic injuries such as 
extremity compartment syndrome, to chronic medical diseases such as diabetes. The materials, 
manufacturing methods and design layouts should be relevant to many other sensor modalities, 
with the potential for co-integration of advanced silicon-based integrated circuits, radio 
communication technologies, power supply and energy harvesters—each adapted from advances 
in transient electronics. Thus, it is realistic to expect that these devices could be used in sensing, 
recording, stimulating, and electrical control for medical monitoring and treatment, not only for 
the body regions explored here but also for areas such as the cardiac space and spinal system. 
Translating these technologies into clinical settings should provide patients and medical 
professionals with a vital set of tools for combating human disease. 
 
1.5 Methods 
Fabrication of bioresorbable silicon pressure sensors. Procedures involved integration of 
silicon-based, piezoresistive sensing elements onto substrates of PLGA, bonded over cavities 
etched into the surfaces of nanoporous Si (np-Si) substrates or magnesium foils. Solid-state 
diffusion of boron yielded highly doped p-type monocrystalline silicon nanomembranes (Si 
NMs) on silicon-on-insulator (SOI) wafers (top silicon ~300 nm thick, p-type; SOITEC, France). 
Eliminating the buried oxide with hydrofluoric acid allowed transfer of the Si-NMs onto a 
bilayer of D-PI (diluted polyimide (poly(pyromellitic dianhydride-co-4,4′-oxydianiline)), ~200 
nm)/PMMA (poly(methyl methacrylate), ~300 nm) on temporary silicon carrier substrates. 
Photolithography and etching patterned the Si NMs into structures with serpentine designs. 
Electron-beam evaporation and spin-casting defined uniform layers of SiO2 (~100 nm) and D-PI, 
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respectively, to serve the purpose of passivation. Selective dry etching through all of the layers 
(D-PI/SiO2/D-PI/PMMA) formed a mesh structure that enabled release in acetone, for transfer to 
a film of PLGA (~30 μm). Heating these films to temperatures near the glass transition of the 
PLGA (65 °C) and laminating them onto np-Si substrates (or magnesium foils, ~60–80 μm) with 
square regions of etched relief (~30–40 μm) formed sealed air cavities upon cooling to room 
temperature.  
Calibration of the pressure response. Responses of commercial sensors under 
environments similar to those in the intracranial cavity allowed absolute pressure calibration for 
the bioresorbable devices. The experiments involved placin a bioresorbable pressure sensor 
inside the barrel of a syringe partially filled with ACSF (Ecocyte BioScience, USA) and with a 
commercial sensor (NeuLog, USA) located at its open end (orifice). Moving the plunger 
component of the syringe allowed reversible access to well controlled pressures throughout a 
range relevant to intracranial monitoring (Fig. 1.10). Comparison of the electrical resistance of 
the bioresorbable sensor (via data acquisition (DAQ) system USB-4065, National Instruments, 
USA) with pressures from the commercial sensor yielded calibration curves.  
Connections to wireless data-transmission systems. Laser cutting of foils of molybdenum 
(~10 μm thick) or magnesium (~50 μm thick) yielded dissolvable narrow metal strips (that is, 
interconnection wires, 80 μm × 30 mm). Pressing these wires against PLGA substrates using a 
PDMS stamp at 65 °C embedded them into the surface of the PLGA. Sputter deposition of 
molybdenum (~2 μm) through high-resolution stencil masks (12.5 μm, Kapton; Dupont, USA) 
yielded electrical connections between the wires and contact pads on the PLGA (Fig. 1.22). The 
opposite ends of the wires connected to externally mounted wireless communication systems 
(Pinnacle Technology, USA) (Fig. 1.23).  
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Evaluation of the kinetics of device dissolution. Measurements of time-dependent 
changes in the thicknesses of square (100 μm × 100 μm) Si-NMs (~200 nm thick), electron-beam 
evaporated layers of SiO2 (~100 nm), free-standing nanoporous silicon substrates (np-Si, ~80 
μm) and magnesium foils (~80 μm) due to immersion in ACSF at body temperature (37 °C) 
established the dissolution kinetics of the key materials. Removing samples from the ACSF 
every other day, rinsing them with deionized water, and measuring the thicknesses by 
profilometry (Dektak, USA) yielded the dissolution rate, as in Figure 1.17. Sealed reservoirs of 
PDMS with viewing windows allowed for observation of dissolution behaviour at the level of the 
completed devices. These engineered structures included access channels around the periphery to 
allow passive fluid exchange and diffusion with a surrounding bath (Figure 1.18). 
Evaluation in animal models. Studies were performed in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health. The protocol was approved by the Institutional Animal Care and Use 
Committee (IACUC) of Washington University in St Louis (protocol number 20140207). Male 
Lewis rats weighing 250–350 g (Charles River, Wilmington, MA) received subcutaneous 
injections of buprenorphine hydrochloride (0.05 mg kg−1; Reckitt Benckiser Healthcare Ltd, 
USA) for pain management, and of ampicillin (50 mg kg−1; Sage Pharmaceuticals, USA) to 
prevent infection at the implantation site before the surgical process. Animals were anaesthetized 
with isoflurane gas and held in a stereotaxic frame for the duration of the surgical procedure and 
measurements. Opening a craniectomy and dural, implanting bioresorbable sensors on the 
cortical surface, sealing the craniectomy with a PLGA sheet (~80 μm thick) and/or 
biodegradable surgical glue, and suturing the skin implanted the fully resorbable biosensing 
system in intracranial space. Comparison testing with a clinical intracranial pressure sensor 
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(Integra LifeSciences, USA) and commercial thermistor (DigiKey Electronics, USA) implanted 
in parallel to bioresorbable sensors demonstrated the functionality of the bioresorbable sensors. 
To implant the injectable device, the same procedure of opening a craniectomy and dural was 
performed. Injecting needle-shaped biosensors into the brain parenchyma (~5 mm deep) with a 
stereotactic frame and arm enabled monitoring of pressure and temperature in the deep-brain 
parenchyma. The immunohistochemistry tests used five individual rats per stage (2, 4 and 8 
weeks) and device type (np-Si and magnesium-foil substrates). In vivo functionality tests of 
pressure and temperature sensors involved three trials using different batches of devices and 
animals, to establish reproducibility.  
Implantable near-field-communication wireless system. The sensor introduced in Fig. 
1.20a can be integrated with sub-dermal wireless data-transmission systems, constructed largely 
of bioresorbable materials, via thin, bioresorbable wires that pass through the skull. Figure 1.35a 
and b show an illustration of a chipscale, near-field-communication (NFC) technology that 
includes bioresorbable coils, polymer substrates, encapsulation layers and resistors, a partially 
bioresorbable NFC chip, and non-resorbable capacitors, and a picture of this system integrated 
with a bioresorbable pressure sensor via biodegradable wiring. Here, micro-patterned magnesium 
coils (50 μm thick, outer diameter 15 mm) allow inductive coupling to an external data reader for 
power transfer and data transmission. A silicon-based logic chip (RF430FRL152H, Texas 
Instruments, USA; 4 mm × 4 mm × ~300 μm) captures the measured data at a high acquisition 
rate, then digitizes and processes the information for transmission to the external reader. Passive 
components include Si-NM resistors and capacitors. PLGA serves as the substrate and electrical 
passivation layer. Figure 1.35c summarizes the operating principles. The external reader 
wirelessly delivers power for operating the logic chip and provides the small currents needed to 
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assess the response of the piezoresistive and thermoresistive sensors. In particular, changes in 
resistance associated with changes in pressure and temperature register as voltages that can be 
recorded and transmitted to the external reader by the NFC chip through the associated coil 
antenna. This NFC system is far more sophisticated than a conventional radio-frequency-
identification (RFID) tag. Here, a single chip platform provides all of the computing 
functionality needed for high-speed data recording, real-time software filtering, and wireless 
transmission of sensor outputs a s captured with an on-board 14-bit analogue-to-digital converter.  
This system communicates through biofluids and tissue with little loss, owing to the use 
of magnetic coupling in a relatively low-frequency band (13.56 MHz; Fig. 1.36), consistent with 
negligible heating associated with system operation (Fig. 1.37). These characteristics enable 
communication distance of up to 25 mm through biological tissue. The high-speed, 
programmable operation of the NFC chip is critical to overall operation. Figure 1.38a presents 
examples of data-acquisition rates of up to 250 Hz, via recordings of oscillating voltages (sine 
wave) with frequencies from 1 Hz to 50 Hz. Spectrograms and other related data appear in 
Figure. 1.38b–d. These high sampling rates allow efficient operation of digital filtering 
algorithms, and they also foreshadow the ability to measure biosignals such as EEG, ECoG and 
ECG. Figure 1.39 demonstrates the response of real-time high/low-pass filter function achieved 
by software programming for on-board computation with the NFC chip. Figure 1.40 shows two-
channel operation of the system with/without this type of filtering during sensing. This integrated 
system provides wireless operation that compares quantitatively with that of a commercial wired 
sensor (Fig. 1.41).  
The wireless module is largely bioresorbable, as illustrated in Figure 1.35d through 
images at various stages of dissolution in ACSF at 60 °C. The magnesium coils, electrodes, 
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interconnects and silicon resistors (240 mg; ~85% of the total mass of the NFC system) dissolve 
fully after 14 days. Here, the NFC chip is not bioresorbable; but fully bioresorbable 
complementary metal-oxide semiconductor (CMOS) circuit technologies offer the potential for 
constructing bioresorbable chips. In particular, recently reported schemes demonstrate that 
modest modifications to otherwise conventional semiconductor-manufacturing techniques allow 
the use of foundry fabrication facilities for construction of bioresorbable CMOS34. Even with the 
examples presented here, where the NFC chip is not fully bioresorbable, the associated 
implantation strategy minimizes risk by locating the hardware subdermally on the skull, outside 
the intracranial space, thereby allowing rapid, facile extraction.  
In this overall architecture, the fully bioresorbable sensors reside in the intracranial space, 
while the NFC system resides extracranially within the subgaleal layer of the scalp. Fine, 
dissolvable wiring provides electrical interconnections through a burr hole in the skull, sealed 
with a bioresorbable surgical glue. After completing the subgaleal closure, the wireless system 
and sensor are fully implanted. Figure 1.35e–h show a diagram of the implantation strategy, 
surgical process, and wireless in vivo intracranial pressure and temperature results measured in a 
rat model. Here, all of the components in the intracranial region are fully bioresorbable. The non-
bioresorbable components of the system remain extra-axial within the scalp, thereby minimizing 
the risk of provoking pathological neuroinflammation in the intracranial space. In addition, the 
relative material safety (as judged by the US Food and Drug Administration (FDA) class) of, for 
example, a subdermally implanted encapsulated non-resorbable device (such as an RFID chip) is 
similar to that of a titanium fixation screw. Removal of an extra-axial component involves a 
much lower risk than intracranial surgery. Intracranial pressure and temperature values measured 
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in the rat model using the NFC system are comparable to those captured using commercial wired 
sensors.  
Fabrication of a fully implantable NFC wireless system. The magnesium foil was 
patterned on the PDMS by using photolithography and etching with dilute hydrochloric acid 
(deionized water:HCl = 15:1). Transfer printing of the patterned magnesium foil onto a film of 
PLGA (~150 μm) formed the inductive coil and electrode. The Si-NM resistor was formed on 
the SOI wafer by doping with phosphorus at 950 °C and patterning the top silicon (~300 nm 
thick) into the trace. Undercutting the buried oxide with hydrofluoric acid and transfer printing 
Si-NM on PLGA formed the resistor of NFC system. Laminating the top PLGA (~150 μm) and 
heating it at 65 °C yielded the passivation layer. Biodegradable conductive W paste served to 





Table 1.1 Hydrolysis mechanisms and dissolution rates of key materials in this study (ACSF and 








Figure 1.1 Bioresorbable, silicon-based mechanical/physical/chemical sensors for biomedical 
applications. a, Schematic illustration of a biodegradable pressure sensor. The inset shows the  
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Fig. 1.1 (cont.) location of the siliconnanomembrane (Si-NM) strain gauge. b, Optical 
micrograph of the strain-gauge region. ‘Trench BD’, boundary of the trench. c, Image of a 
complete device. The outer diameter of the hypodermic needle is 1 mm. d, Left, distribution of 
principal strains across the PLGA layer, including the Si-NM strain gauge at the left edge, 
determined from finite element analysis (FEA) for an external pressure of 50 mm Hg. Right, 
corresponding displacement profile evaluated along the red dotted line in the left panel. εmax and 
dz are the principal strain and vertical displacement, respectively. e, Responses of a commercial 
pressure sensor (blue) and a calibrated biodegradable device (red) to time-varying pressure over 
a range relevant to intracranial monitoring. f, Response of a similar biodegradable device (red), 
but configured as an accelerometer, with comparison to a commercial sensor (blue). g, 
Comparison of the calibrated response of such a bioresorbable temperature sensor (red) to a 
commercial device (blue). h, The difference in temperature measured by two separate Si-NM 
temperature sensors placed near a Si-NM element for Joule heating allows assessment of flow 
rate. i, A single serpentine Si-NM used as both a temperature sensor and a heating element 
allows measurements of thermal conductivity and heat capacity. The graph shows time-
dependent changes in temperature upon actuation of Joule heating in devices immersed in 
different liquids. The coefficients of thermal conductivity (ĸ, measured through the rate of 
resistance change) of hexane, toluene, ethylene glycol, and water are 0.12, 0.13, 0.26, and 0.60 
W m−1 K−1, respectively. j, When the Si-NM is exposed to aqueous surroundings, its 
conductance depends on pH. The graph shows measurements for immersion in solutions with pH 
values between 2 and 10. k, Images collected at several stages ofaccelerated dissolution of a 
bioresorbable pressure sensor upon insertion into an aqueous buffer solution (pH 12) in a 




















Figure 1.3 Scanning electron microscope (SEM) images of nanoporous Si. a) Crosssection view 








Figure 1.4 Biodegradable pressure sensor with Mg trench structure. Trench depth and thickness 









Figure 1.5 Image of a bioresorbable pressure sensor, with a thickness of ~110 μm, a weight of 
~1 mg and overall lateral dimensions of 3 mm × 6 mm and trench dimensions of 2 mm × 2.4 mm 

















Figure 1.7 Optimization of trench geometry through stress-strain analysis using the finite 
element method (FEM). a) Full image of simulated dimension. b) Principle strain distribution 
around the piezoresistive serpentine sensors for various trench geometries. εa represents average 






Figure 1.8 Piezoresistive response of the pressure sensor compared to finite element method 















































Figure 1.12 Transient accelerometer with Si-NM piezoresistive strain sensor. a) Materials and 
structure of accelerometer with PLGA proof mass. b) Image of bioresorbable accelerometer on 








Figure 1.13 Bioresorbable temperature sensor on a thin PLGA film. a) Materials and structure of 
a thermoresistive Si temperature sensor. b) Microscope image of a dense serpentine Si-NM 

































Figure 1.15 Principle of flow rate monitor based on a thermal actuator and a pair of temperature 
sensors. The difference between the temperatures recorded at the two temperature sensors (T2-













Figure 1.17 Hydrolysis kinetics of materials used in the bioresorbable pressure sensors. 
Normalized thickness (h/h0) as a function of time during dissolution of individual materials in 
artificial cerebrospinal fluid (ACSF) at physiological temperature (37 °C). The initial thicknesses 
were 200 nm for Si nanomembranes (Si NMs), 80 μm for porous Si (p-Si), 80 μm for Mg foil, 













Figure 1.18 Schematic diagram (left) and image (right) of PDMS structure used as a simple 








Figure 1.19 Scanning electron microscope (SEM) images of a) Si NMs and b) np-Si at the 
















Figure 1.20 Bioresorbable interfaces between intracranial sensors and external wireless data-
communication modules with percutaneous wiring. a, Image of bioresorbable pressure and 
temperature sensors integrated with dissolvable metal interconnects (sputtered molybdenum, Mo, 
2 μm thick) and wires (Mo, 10 μm thick). The inset shows an optical micrograph of the 
serpentine Si-NM structures that form the sensing regions. The Si-NM that is not above the air 
cavity (left) responds only to temperature; the one at the edge of the air cavity (right) responds 
primarily to pressure. b, Diagram of a bioresorbable sensor system in the intracranial space of a 
rat, with electrical interconnects that provide an interface to an external wireless data-
transmission unit for long-range operation. c, d, Demonstrations of c, an implanted bioresorbable 
sensor in a rat, and d, a sutured individual. A thin film of PLGA (~80 μm) and a degradable 
surgical glue (TISSEAL) seal the craniectomy defect to close the intracranial cavity. e, Healthy, 








Figure 1.21 Calibration of the temperature dependent piezoresistivity. a) Resistivity variation to 
applied pressure at various temperatures (error bars represents standard deviation). b) Variation 
of sensitivity of resistivity to pressure associated with changes in temperatures. The change of 











Figure 1.22 Strategy for interconnection between a bioresorbable device and degradable external 
wires on biodegradable polymer. Transfer printing the biodegradable wires (Mg or Mo) on the 
biodegradable polymer substrate (PLGA), and depositing dissolvable metal (Mo) between the 














Figure 1.24 Wireless measurement of intracranial pressure and temperature with bioresorbable 
sensors implanted in live, freely moving animals. a–e, Red, data from a transient, bioresorbable 
sensor; blue, data from a commercial sensor. a, Real-time wireless measurements of ICP, 
showing transient increases induced by the Valsalva manoeuvre. b, In vivo observation of 
changes in ICP as a function of time in the Trendelenburg and reverse Trendelenburg positions. 
ICP increases in the 30° head-down position (Trendelenburg) as compared with the supine 
position, and decreases in the 30° head-up position (reverse Trendelenburg). c, Gradual increase 
and d, decrease in ICT due to application of a heating/cooling blanket. e, Measurements of ICP 
over three days reveal consistent responses from devices encapsulated with biodegradable 
polyanhydride. f, Confocal fluorescence images of the cortical surface beneath the dissolved 
device at 2, 4 and 8 weeks, showing the absence of inflammatory responses. The images are 
doubleimmunostained for GFAP (glial fibrillary acidic protein) to detect astrocytes (red), and 
Iba1 (ionized calcium-binding adaptor molecule 1) to identify microglia/macrophages (green). 





Figure 1.25 Effect of polyanhydride encapsulation on the response of the pressure sensor. a) 
Calibration curves before and after encapsulation. The calibration factor changes from 82 to 50 
Ω/mmHg with 120 μm thick encapsulation (error bars represent standard deviation). b) The 







Figure 1.26 Chemistry of synthesis and hydrolysis of a biodegradable polymer (class of 






Figure 1.27 a) Dissolution kinetics and b) water permeability (tested by 300 nm thick Mg 











Figure 1.28 Hematoxylin and eosin (H&E) images of tissue around the implant site of a) 






Figure 1.29 In vitro operation of bioresorbable pressure sensor with functional lifetime 












Figure 1.30 Effect of dissolution of metal wires and interconnects on the resistance. a) Increases 
in resistance of biodegradable metal wire (Mo, 10 μm; Mg, 50 μm) in ACSF at physiological 
temperature for ~a week. The change in resistance is negligible (below a few ohms) for a week. 
The resistance of Mg wire rapidly increases after 7 days due to its higher dissolution rate 
compared to Mo. b) Changes in resistance of Mo interconnections (~ 2 μm) during hydrolysis in 






Figure 1.31 Resistance measurement of a pressure sensor with polyanhydride encapsulation with 











Figure 1.32 In vitro and in vivo demonstrations of biodegradable temperature sensors. a) 
Calibration curves for resistance to temperature indicate stable operation over 6 days in ACSF. 
b) Stable in vivo operation was demonstrated for three days. Sensors were encapsulated with a 






Figure 1.33 Confocal fluorescence images of the cortical surface. a) Series of images of the 
sham area (left side of brain) and the area underneath the np-Si pressure sensor (right side of 
brain). b) Image of the cortical surface at the site implanted with a Mg supported device and c) at 







Figure 1.34 Animal behavior evaluation with transcutaneous wire implantation using novel 





Figure 1.35 Fully implantable near-field communication (NFC) system with bioresorbable 
interface and intracranial sensors. a, Diagram of a fully implantable NFC system. This device 
uses a magnesium foil (~50 μm) for the inductive coil, interconnects and electrodes; patterned 
silicon nanomembranes (Si-NMs, ~300 nm) for resistors; conventional capacitors; and an 
advanced NFC microchip for data acquisition, processing and transmission. PLGA serves as the 
substrate and for encapsulation. The diameter of the entire device is about 15 mm. b, Image of 
this type of NFC system integrated with a bioresorbable pressure sensor. c, Diagram of the 
operational principles. d, Series of images showing accelerated dissolution of the NFC system 
inserted into an ACSF at 60 °C. e, Diagram of the implantation process. The bioresorbable 
sensors reside in the intracranial space, while the NFC system is located extracranially, on the 
outside surface of the skull, beneath the skin. Bioresorbable, thin metal wires interconnect the  
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Fig. 1.35 (cont.) NFC system and the sensors. f, Real-time wireless measurements of ICP, 
showing transient increases induced by the Valsalva manoeuvre (red, data obtained from a 
transient ICP sensor; blue, data obtained from a commercial ICP sensor). g, Increase in ICT 
owing to application of a heating blanket around the head, as determined by bioresorbable (red) 
and commercial (blue) sensors. h, Demonstrations of implantation and suturing in a rat model. A 



















Figure 1.36 Frequency dependent a) impedance and b) phase of the NFC system at the different 
distance (black line; 10 mm, red dot; 10 mm with 2 mm barrier of phosphate buffer solution 

















Figure 1.38 High sampling rate of NFC system. a) Wirelessly transmitted voltage sine waves 
with frequencies between 1 to 50 Hz. Maximum sampling rate of this system is 250 Hz. b) 
Spectrogram of swept sine wave in Figure 1.20f. High speed data acquisition of NFC system 
demonstrated with c) sine and d) square wave of 10 Hz frequency. (Red dot line is the data point 










Figure 1.39 Gain response of programmed real-time high (red) and low (blue) pass filtering, 












Figure 1.40 Comparison of filtered (red) and unfiltered (black) gain during pressure 
measurement. Two channels were measurement through NFC system at the same time. The filter 






Figure 1.41 Response of a commercial pressure sensor (blue) and a wireless, biodegradable 








Figure 1.42 Application of bioresorbable sensors to various body cavities, and demonstration of 
an injectable format for deep brain monitoring. Red, data from a transient biodegradable sensor; 
blue, data from a commercial sensor. a, b, Pressures measured in a, intra-abdominal and b, leg 
cavities. c, Image showing in vivo injection of a needle-shaped biodegradable pressure sensor 
(using a magnesium foil support, ~80 μm thick) into the brain parenchyma with a stereotactic 
frame and arm. The inset shows a biodegradable pressure sensor inserted into hydrogel, as 
evidence of the sensor’s robust mechanical construction. d, In vivo measurements of pressure in 
the deep brain. e, In vivo measurements of temperature in the deep brain during anaesthesia. The 







Figure 1.43 Geometry of needle substrates of pressure sensor. a) Lateral geometry and b) three-







Figure 1.44 Surgical process for injectable form of biodegradable sensors. A needle shaped 
sensor was positioned with a jig. Lowering the jig causes the sharp edge of the device to 
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CHAPTER 2: BIORESORBABLE PRESSURE SENSORS WITH THERMALLY-




Measurements of pressure in organ systems ranging from the brain, eyes, bladder, and 
blood vessels form an essential diagnostic basis for assessment of patient health and progression 
of diseases such as glaucoma (intraocular pressure), hypertension (blood pressure), traumatic 
brain injury, and hydrocephalus (intracranial pressure). Capabilities in precise, continuous 
monitoring of pressure can, therefore, be critically important in defining treatment protocols that 
decrease the rate of morbidity and increase the pace of recovery1-3. Conventional sensor 
technologies designed for this purpose are available in the form of accurate, implantable devices 
that must be surgically extracted after a patient has emerged from the most critical stages of the 
recovery process. These procedures are costly and they can expose the patient to significant pain 
and risks for complications4. Additionally, the devices can serve as a nidus for infection5,6 and 
for immune-mediated inflammatory responses7. Emerging classes of bioresorbable electronic 
sensor systems have the potential to address these disadvantages. Here, all of the constituent 
materials dissolve in biofluids over well-defined periods of time, with biologically benign end 
products. This process naturally eliminates the devices after a useful functional period, thereby 
bypassing surgical extraction. Examples of bioresorbable devices in the recent literature include 
biophysical sensors of pressure, temperature, flow rate, and motion8,9 together with several types 
of biochemical sensors8,10. Additional components range from thermal actuators8 to neural 
electrodes11,12, power supplies13, and controlled drug-delivery vehicles14,15. Published animal 
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model studies include deployments in the intracranial, intra-abdominal and leg cavities8, on 
cortical surfaces11,12, and in subdermal regions15,16.  
Although recently reported bioresorbable pressure sensors offer sensitivity and accuracy 
comparable to those of conventional, non-resorbable analogs, they offer stable operation over a 
period of only several days, which is insufficient for many applications8,9. Extending this 
operational lifetime to several weeks involves daunting challenges in materials science and 
device design that follow directly from the requirement that the systems must ultimately dissolve 
completely, at a molecular level, without adverse effect.  This difficulty is inherent to all classes 
of implantable, bioresorbable systems because immersion in biofluids immediately initiates 
processes of bioresorption.  The most effective means to prolong the lifetime relies on passive 
encapsulating layers that delay the time required for biofluids to come into contact with the 
active materials.  Biodegradable polymers such as silk fibroin15,16, poly(L-lactide) (PLLA)9, and 
poly(lactic-co-glycolic acid) (PLGA)13 are attractive for such purposes, partly because they can 
be formed easily by spin-coating or molding.  The hydrophilic nature of these materials, however, 
leads to swelling and water permeation, thereby causing premature fracture, buckling and 
dissolution of the underlying materials.  Inorganic alternatives based silicon dioxide17,18, silicon 
nitride18, and various metal oxides19 formed by chemical or physical vapor deposition offer 
exceptionally slow rates of dissolution without these other adverse responses.  Nevertheless, 
these materials are of limited practical utility due to extreme difficulties in forming coatings 
without cracks or pinholes that can allow water to pass.  
Recent work demonstrates that layers of silicon dioxide thermally grown on device-grade 
silicon wafers (t-SiO2) can serve as biofluid barriers with defect-free, material perfection over 
large areas20,21. Systematic studies show that the eventual failure follows from hydrolysis 
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reactions, as opposed to water permeation through the material or through defects in the films. 
Specifically, t-SiO2 dissolves in simulated biofluids at physiological temperatures with rates of 
several hundredths of a nanometer per day, to yield silicic acid as a biodegradable end 
product18,20,21.  These observations suggest the use of ultrathin layers of t-SiO2 as bioresorbable 
encapsulation layers to enable stable operating periods in the range of weeks or longer.  This 
materials strategy has the potential to yield devices that can address operational lifetime 
requirements for envisioned clinical applications, including those in monitoring of pressure for 
traumatic brain injury (up to one week)22 and glaucoma (several months), as examples. The 
principal design strategy includes: (1) t-SiO2 barriers that prevent interactions with biofluids 
throughout the desired monitoring period, but with thicknesses sufficiently small to allow 
complete bioresorption within a reasonable timeframe, typically less than a year; (2) structural 
components that dissolve in a manner that does not affect the measurement accuracy; and (3) 
interlayer bonding approaches that prevent interfacial water penetration from the periphery.  
Here, we demonstrate materials, device structures, fabrication methods that adhere to this 
strategy.  The overall approach relies on bonding of a pair of silicon-on-insulator wafers using 
adhesion layers of amorphous silica formed by calcination of poly(dimethylsiloxane) (PDMS).  
Eliminating the handle wafers after bonding yields ultrathin, inorganic bioresorbable electronic 
devices with robust biofluid barriers that allow stable operation over extended periods of time.  
Data on the biodistribution of dissolved silicon in mice at five weeks following implantation of 
intracranial sensors formed in this manner, together with assessments of the hematology 
(complete blood count) and the blood chemistry confirm their nontoxicity and biodegradability. 
Measurements of intracranial pressures in rats over 25 days illustrate high accuracy and low drift, 
with overall performance that compares favorably to that of non-resorbable clinical standards. 
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The results not only establish routes to bioresorbable pressure monitoring technologies that meet 
requirements for clinical use, but they also serve as a generalizable platform for broad classes of 




The procedures for fabrication of bioresorbable pressure and temperature sensors with 
thermal SiO2 biofluid barriers began with mechanical back-grinding (Syagrus Systems, USA) to 
reduce the total thickness of a silicon-on-insulator (SOI-A) wafer (top Si ~200 nm, buried SiO2 
~1 μm, Si wafer ~100 μm; SOITEC, France) prior to device fabrication. Solid-state diffusion of 
phosphorus at 950oC followed by photolithography and reactive ion etching (Plasma-Therm 
RIE) defined silicon nanomembrane strain gauges (Si NM SGs) and temperature gauges (TGs) in 
the top Si of SOI-A. Electron-beam (e-beam) evaporation of SiO2 pellets (99.99%; Kurt J. 
Lesker Company, USA) formed a layer of SiO2 (~600 nm) on top. Photolithography and deep 
reactive ion etching (STS Pegasus ICP-DRIE) defined an array of vent holes (area: 100 μm x 100 
μm) through the thickness of SOI-A. Photolithography and ICP-DRIE formed a square trench 
with dimensions of 200 μm x 200 μm x 10 μm on a separate SOI wafer (SOI-B, top Si ~15 μm, 
buried SiO2 ~600 nm, Si wafer ~85 μm after mechanical grinding; University Wafer, USA).  
Wafer bonding of SOI-A (silicon sensors) and SOI-B (silicon trench) involved spin-
coating a layer of diluted poly(dimethylsiloxane) (PDMS, part A/part B/hexane = 10:1:100, 
Sylgard 184; Dow Corning, USA) at a speed of 3000 rpm for 30 seconds on SOI-B, partially 
curing the PDMS by heating the wafer at 110 oC for 1 minute, transferring SOI-A on top of the 
SOI-B in a manner that aligned the SGs of SOI-A directly above the trench of SOI-B, pressing 
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the wafers together in a steel vise (Toomaker’s vise; Tormach, Inc., USA), and fully curing the 
PDMS by placing the vise in a 70 oC convection oven for 2 hours bonded the wafers. Heating the 
vise in a furnace, by raising the temperature to 550oC over 2 hours and keeping there for 2 more 
hours, converted the PDMS adhesion layer to amorphous silica.  
Then, ICP-DRIE removed the top Si wafer (SOI-A) of the bonded sample to expose the 
buried oxide.  Wet etching in a buffered oxide etchant (BOE, 6:1; Transene Company Inc., USA) 
reduced the thickness of this oxide to the desired value (~10 nm). Patterned wet etching exposed 
square areas (~100 μm x 100 μm) of Si NM in the four corners.  Profilometer (Alpha Step D-
500; KLA Tencor, USA) measurements confirmed the thickness of the buried oxide, with 
additional wet etching as needed to reach the desired value. Sputtering a layer of molybdenum 
(~100 nm) followed by patterning and wet etching formed metal contact pads (area: 150 μm x 
150 μm) on top of the four exposed areas of Si NM. Spin-coating a layer of photoresist on the 
top surface, etching bottom Si wafer and buried oxide (SOI-B) by ICP-DRIE and wet etching in 
BOE, and removing the photoresist by descum process (March RIE) completed the fabrication.  
 
2.3 Results and Discussion 
 Figure 2.1a shows the steps for fabrication, beginning with formation of silicon 
nanomembrane (Si NM) sensors on a silicon-on-insulator wafer (SOI-A, top Si ~200 nm, buried 
SiO2 ~1 µm, Si wafer ~100 µm after mechanical grinding; SOITEC, France). Solid-state 
diffusion of phosphorus at 950 oC followed by photolithography and reactive ion etching 
(Plasma-Therm RIE) yields piezoresistive strain gauges in the top Si. Electron beam evaporation 
forms a coating of SiO2 (eb-SiO2, ~600 nm) that defines the thickest region of the sensing 
diaphragm of the final device. Photolithography and deep reactive ion etching (STS Pegasus 
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ICP-DRIE) create an array of holes (area: 100 µm x 100 µm) through the thickness of the wafer 
to release gaseous produces of the calcination process described subsequently. Patterning and 
etching the top Si layer of a second SOI wafer (SOI-B, top Si ~15 µm, buried SiO2 ~600 nm, Si 
wafer ~85 µm after grinding; University Wafer, USA) creates a trench with dimensions of 200 
µm x 200 µm x 10 µm. Spin-coating a thin layer of poly(dimethylsiloxane) (PDMS) on SOI-B 
allows bonding to SOI-A via thermal curing while applying pressure with a steel vise (Tormach, 
Inc., USA). Heating the vise in a furnace at 550 oC for 2 hours calcines the PDMS adhesion 
interlayer to yield an amorphous silica material (~200 nm) via a thermal oxidative degradation 
process23. Gaseous by-products such as carbon dioxide and water escape the bonding interface 
via the vent holes, leaving behind a smooth film of silica. Figure 2.2 shows scanning electron 
microscope (SEM) and atomic force microscope (AFM) images. A single broad peak at ~-110 
ppm in the 29Si NMR spectrum of the silica (Fig. 2.3) confirms full conversion of PDMS (no 
peak around -21 ppm, where SiO2(CH3)2 would appear) into amorphous SiO2 (Si-(O-Si)4, Q4 
site). Electron dispersive spectroscopy (EDS) also confirms the absence of carbon. Removing the 
handle wafer of SOI-A by ICP-DRIE exposes the buried oxide underneath, to allow thinning to a 
desired thickness (~10 nm) by immersion in a buffered oxide etchant. Patterned wet etching 
exposes the Si NM in the four corners, to allow formation of electrical contact pads (area: 150 
µm x 150 µm) using bioresorbable metals (molybdenum, 100 nm). ICP-DRIE followed by wet 
etching eliminates the handle silicon and buried oxide of SOI-B, respectively.  
Figure 2.1b shows a photograph of a representative device, with size and weight of 1.3 
mm x 1.3 mm x 16 µm and ~60 µg, respectively. The system consists of four Si sensors, two of 
which serve as strain gauges (SGs, blue) and two as temperature gauges (TGs, red), depending 
on their position relative to the trench (Fig. 2.1c). The partial extension of SGs over the trench as 
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part of a floating diaphragm yields a response that depends on the mechanical equilibrium 
between the pressures of the surroundings and that of the air trapped inside the trench.  The TGs 
are not located over the trench and are therefore unresponsive to changes in pressure. These four 
gauges combine to form a Wheatstone bridge circuit to compensate temperature effects on the 
piezoresistive response of the SGs24.  
A magnified view of the diaphragm appears in Figure 2.1d. Two gray lines (width ~5 
µm) represent etched regions of the Si NM that isolate each SG (pink, width ~8 µm) from the 
surrounding silicon. The diaphragm has an area of 200 µm x 200 µm, defined by lateral 
dimensions of the trench, and consists of a tri-layer of thermal SiO2 (t-SiO2, ~10 nm), 
monocrystalline Si (~200 nm), and eb-SiO2 (~600 nm). The t-SiO2 layer, derived from the buried 
oxide of the SOI-A wafer, insulates the Si devices from exposure to biofluids, thereby extending 
their functional lifetime. The eb-SiO2 layer constitutes the thickest part of the diaphragm, and 
serves to increase the vertical separation between the neutral mechanical planes of the SGs and 
the bulk membrane, thereby improving the response of the SGs to pressure.  
Three-dimensional finite element analysis (3D-FEA) provides insights into the mechanics 
of pressure sensing using these constructs. Distributions of principal strain and vertical 
displacements associated with the diaphragm under an external pressure of 40 mmHg above 
atmospheric appear in Figure 2.1e. The maximum strain for any applied pressure over the range 
of interest occurs along the edge of the trench, where the SGs are located. The relationship 
between the resistance of a SG and pressure is linear with a slope of -0.13 Ω/mmHg, which 
corresponds to a gauge factor of about -20.9, consistent with theory (see Methods and Fig. 2.4 
for details). The value of the gauge factor follows from the heavy doping of the top Si (step 1 in 
Fig. 2.1a) needed to allow phosphorus atoms to diffuse through its thickness to the base (Fig. 
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2.5), at the location of electrical contact pads formed as a result of wafer bonding and etching 
(steps 4-7)25,26. Reducing the thickness of the Si NM (~50 nm), increasing the area of the 
diaphragm (~500 µm x 500 µm), and introducing serpentine designs in the SGs can improve the 
pressure sensitivity (Fig. 2.6). Measurements of the resistance of the TG as a function of 
temperature reveal a linear response with a temperature coefficient of resistance (TCR) of 
0.0012/oC, which lies within a range of expected values for monocrystalline silicon (Fig. 2.7)26,27. 
Changes in pressure sensitivity due to changes in temperature within the relevant ranges for the 
intracranial space (34-40 oC) induce errors in measured pressures that are less than ±0.4 mmHg 
(Fig. 2.8).  
In vitro evaluations that mimic thermodynamic conditions inside the intracranial space 
illustrate the functional capabilities of the device. An airtight plastic chamber filled with artificial 
cerebrospinal fluid (ACSF, pH 7.4) at physiological temperature (37 oC) and connected via tubes 
to a commercial pressure sensor (Neulog, USA) and a syringe allows measurement and control 
of pressure, respectively (Fig. 2.9). Comparing voltage responses of the sensor (red, Vs = 2.5 V) 
with the measured pressures (blue) for values over a range relevant to intracranial monitoring 
reveals a linear correspondence (Figs. 2.1f and 2.10a). The level of noise in the response of the 
bioresorbable sensor, evaluated as the difference between the pressures measured by 
bioresorbable and commercial sensors (noise floor less than ±0.8 mmHg), lies within ±1 mmHg 
in the range of 0-30 mmHg and within ±3 mmHg in the ranges above (Fig. 2.10b). These 
numbers meet the intracranial pressure (ICP) monitoring standards defined by the Association 
for the Advancement of Medical Instrumentation (AAMI) (that is, a functional range of 0-100 
mmHg, accuracy of ±2 mmHg in the range of 0-20 mmHg, and maximum error less than ±10 % 
in the range of 20-100 mmHg)28. Comprehensive results from continuous in vitro operation over 
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a period of 22 days reveal variations in pressure sensitivity and baseline within ±1.5 % and ±2.5 
mmHg, respectively (Fig. 2.11). The observed baseline drift is within the expected ranges 
specified for a clinical fiber optic ICP monitor (that is, ±2 mmHg maximum in the first 24 hours 
and ±1 mmHg per day thereafter)29. 
The key feature of this system is that the constituent materials are water soluble, with 
biocompatible end products. Dissolution of Si and SiO2 yields silicic acid Si(OH)4 via hydrolysis, 
according to Si + 4H2O → Si(OH)4 + 2H2 and SiO2 + 2H2O → Si(OH)4, respectively. Figure 
2.12a shows the kinetics, evaluated as changes in thicknesses of films of silicon oxides obtained 
by thermal oxidation, electron beam evaporation, and PDMS calcination in ACSF at T = 37 oC. 
The thicknesses of t-SiO2 and eb-SiO2 layers can be quantified by spectroscopic reflectometry 
(MProbe), while those of the silica adhesion layer can be assessed most effectively by 
profilometry (Alpha Step) due to non-uniformities in film thickness that follow from calcination. 
Figure 2.13 shows the steps for fabricating arrays of square patterns of silica used in the study, 
along with an image of these structures. The layers of t-SiO2, eb-SiO2 and silica dissolve at rates 
of 0.11 ± 0.01, 13.6 ± 1.6, and 129 ± 9 nm/day, respectively. The rates of dissolution of single-
crystalline silicon and biodegradable metals (Mo, Mg) appear elsewhere8,11. These rates, taken 
together with the overall structures of the devices, yield estimated times for full dissolution of 
~400 days. By decreasing the thickness of the trench (~10 µm), this time can be reduced to 
approximately 290 days without significantly compromising the sensor response.  
Figure 2.12b shows a schematic illustration of a set-up designed to dissolve bioresorbable 
sensors at accelerated rates by immersion in phosphate-buffered saline (PBS, pH 7.4) at T = 95oC 
in a plastic bottle. Employing a test design in which the sensor uses a t-SiO2 substrate (by 
omitting step 8 in Fig. 2.1a) allows unidirectional thinning of component layers in sequence from 
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top to bottom. Figure 2.12c presents optical micrographs collected at various stages of 
dissolution. Complete hydrolysis of the t-SiO2 layer leads to exposure of the Si NM within 5 
hours; fast and non-uniform dissolution of the silicon creates a rough surface profile, which 
appears as dark shades under the microscope. The eb-SiO2 and silica adhesion layers disappear 
within 20 hours, followed by the Si trench (outer gray region) in 80 hours. Complete 
disintegration leaves only the surface of the t-SiO2 substrate with a shallow feature of surface 
relief (pink). 
The use of t-SiO2 as a defect-free barrier to prevent biofluid penetration to the Si device 
layer is critically important to the robust, long-lived operation. The functional lifetime is 
proportional to the thickness of the t-SiO2 (Fig. 2.12d)20. Calibration curves of a bioresorbable 
pressure sensor (~10 nm t-SiO2) collected at constant time intervals after immersion of the 
device in PBS at T = 95oC indicate highly uniform pressure responsivity in the first 3 hours 
followed by rapid transience. Operational failure follows from formation of holes or cracks in the 
diaphragm after dissolution of the t-SiO2.  
Evaluating the biodistribution of dissolved silicon, the hematology (complete blood 
count), and the blood chemistry of mice implanted with bioresorbable intracranial sensors 
provides insights into the body reactions to these devices as bioresorbable implants. Use of 
miniaturized devices (size: 750 µm x 750 µm x 11 µm; weight ~12 µg) without t-SiO2 
encapsulation accelerates the dissolution, thereby facilitating evaluations over a five-week period 
of study. The surgical procedure includes opening a craniectomy defect penetrating through the 
dura, implanting the sensor, and sealing the intracranial cavity using a drop of biodegradable 
tissue adhesive (TissueSeal, USA).  
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Figure 2.14a shows concentrations of silicon in liver, spleen, heart, kidney, brain, and 
lung tissues explanted from mice at 1, 3, and 5 weeks after implantation, measured by 
inductively coupled plasma optical emission spectrometry (ICP-OES; see Methods for sample 
preparation steps). The results indicate deposition of silicon at higher concentrations in spleen, 
heart, and lung tissues than in the brain, where the device is located, 1 week after implantation. 
This observation can be attributed to fast turnover of CSF volumes in mice (12-13 times per day 
in mice; 3-4 times in humans)30. The CSF circulates through the brain, then joins the 
bloodstream by bulk reabsorption via arachnoid villi, transporting dissolved silicic acids to other 
organs. In particular, mononuclear phagocyte system-related organs such as liver, spleen, and 
lung have phagocytic cells that uptake nanomaterials in the blood, leading to deposition of 
silicon in these organs31. Clearance of silicic acid from the body via excretion through the 
kidneys leads to a gradual decrease and nearly complete removal from most organs after 5 weeks. 
Abnormal levels of silicon in the kidney and brain at week 5, however, suggest presence of 
residual device silicon in the brain, as verified by computed tomography (CT) images taken for a 
mouse at week 5 (Fig. 2.14b). Scans of the mouse brain along the sagittal, coronal, and axial 
planes reveal the locations of the craniectomy defect and a sensor implanted near the top surface 
of the brain, fixed in a tilted angle.  
Results of complete blood count and blood chemistry tests provide a comprehensive 
understanding of the health of the mice (Figs. 2.14c and d). Average counts of white blood cells 
(WBC), red blood cells (RBC), platelets (PLT) and levels of hemoglobin (HGB) and hematocrit 
(HCT, the percentage of red blood cells in blood) show no significant differences between 
implanted mice from those of control animals throughout the five-week period of the studies. 
Blood levels of enzymes and electrolytes, which serve as indicators of organ-specific diseases, 
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also fall within confidence intervals of control values. For example, normal levels of alanine 
aminotransferase (ALT), cholesterol (CHOL) and triglyceride (TRIG), phosphorus (PHOS) and 
urea nitrogen (BUN), calcium (CAL), and albumin (ALB) and total proteins (TP) indicate 
absence of disorders in the liver, heart, kidney, bone and nerve, and good overall health, 
respectively. Complete results for both tests appear in Figs. 2.15 and 2.16.  
Figure 2.17 compares changes in the body weight of mice implanted with intracranial 
sensors to those of control animals. The differences are minimal, indicating continued maturation 
without significant toxic effects. Immunohistochemistry of brain, spleen, heart, and kidney 
tissues from a control mouse and a mouse implanted with a sensor for 5 weeks also show no 
obvious sign of damage, specifically with respect to steatosis, inflammation, and necrosis (Fig. 
2.14e and 2.18). 
Acute and chronic tracking of ICT and ICP in rats demonstrate the accuracy and long 
operating lifetimes of the bioresorbable sensors. Figure 4a illustrates the procedures for 
implantation, which involve opening a craniectomy defect, placing the sensor mounted on a thin 
film of poly(lactide-co-glycolide) (PLGA, ~10 µm thick; inset) inside, and applying 
biodegradable glue to bond the PLGA film with the surrounding skull, thereby sealing the cavity. 
Wired connections to an external data acquisition system allow recordings of ICP from the 
sensor (see Methods for details). Inserting the probe of a standard clinical ICP monitor (Integra 
LifeSciences, USA) through a separate defect on the same hemisphere allows comparison of the 
responses of bioresorbable and clinical standard devices. Storing the electrical connectors of the 
sensor in a plastic hat (Pinnacle Technology, USA, Fig. 2.20), fixed on the skull using dental 
cement (Pentron, USA), prepares the rat for subsequent tests.  
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Figure 2.19b shows acute recordings of the intracranial temperature (ICT) by both a 
bioresorbable device (red) and a commercial thermistor (blue; Digi-Key, USA) during gradual 
heating, using an electrical heating blanket, and cooling, using an ice pack, of the animal, 
indicating similar levels of accuracy. Figures 2.19c-e show recordings of acute variation in ICP 
induced by contracting and releasing the rat’s flank (increase and decrease by ~10 mmHg, 
respectively; Fig. 2.19c), laying the rat in Trendelenburg (30o head-down) and reverse 
Trendelenburg (30o head-up) positions (increases and decreases by ~2 mmHg, respectively; Fig. 
2.19d), and intravenously infusing Mannitol (dose: 2 g per kg weight) via the saphenous vein 
(decreases by 2-5 mmHg starting ~10 minutes after infusion; Fig. 2.19e) using bioresorbable 
(red) and commercial (blue) ICP sensors. Figure 2.19f summarizes ICP signals collected while 
contracting and releasing the flank on days 1, 8, 18, and 25. Responses of the sensor from days 1 
through 18 display absolute accuracy within ±2 mmHg and baseline drift within ±1 mmHg. 
Recordings on day 25 show ~4 mmHg negative drift, in a range consistent with that of clinical 
ICP monitors after several days of implantation without re-calibration29,32-34. Signals from the 
device disappear after day 25, possibly due to the dissolution of the bioresorbable metal pads 
following penetration of water into the sensor-wire interface.  
In many clinical scenarios, patients require magnetic resonance imaging (MRI) at various 
stages of recovery.  Figure 2.21 illustrates in vitro verification of compatibility of a biroesorbable 
sensors with MRI by using gel phantoms (True Phantom Solutions, Inc., Canada) designed to 
imitate the conductivity and dielectric constant of the brain. The set-up consists of a 
bioresorbable sensor and two fiber-optic temperature probes (LumaSense Technologies, USA), 
one near the sensor and the other distant (control), embedded in between two 2 cm-thick slabs of 
the phantom. Recordings of the difference in temperatures measured by the two probes 
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throughout a continuous 20-minute, high-specific adsorption rate (SAR) MRI scan (3 Tesla 
Siemens Magnetom Prisma system) suggest that there is no significant heating associated with 
the presence of the device.  
 
2.4 Conclusion 
The materials, device structures, and fabrication strategies for biomedical sensors 
demonstrated in this study enable bioresorbable implants capable of accurate, stable monitoring 
of pressure and temperature in organ systems to treat chronic diseases that require extended 
periods of operation, previously attained only by non-resorbable devices. In vivo experiments to 
track elemental biodistribution of silicon, hematology, and blood chemistry in mice throughout 
five weeks following implantation of intracranial sensors confirmed their innocuity and 
biodegradability. In vivo monitoring of intracranial pressures in rats over 25 days illustrated high 
accuracy and low drift, which compare favorably to those of non-degradable standard devices. 
These results suggest not only clinical value of these bioresorbable implants, but also utility as a 
generalizable platform for broad classes of bioresorbable electronics, including sensors of motion, 
flow, and various chemical species, as well as stimulators, power supplies, or thermal actuators 
that may benefit from longer in vivo operation times.  
 
2.5 Methods 
Connections to data acquisition systems. Ultrathin enameled copper wires (~80 um 
diameter; Remington Industries, USA) and silver conductive epoxy (MG Chemicals, USA) 
formed electrical connections between the bioresorbable sensor and a digital multimeter (USB-
4065; National Instruments, USA) for data acquisition during in vitro and in vivo experiments. A 
80 
 
100 μm-thick layer of bioresorbable polyanhydride8 encapsulated the sensor-wire interface to 
prevent direct exposure to biofluid.  
Calibration of the pressure response. Absolute pressure calibration of the bioresorbable 
sensor relied on a custom set-up consisting of an airtight container (Nuovoware, USA) connected 
by two plastic tubes to a commercial pressure sensor (NUL-210; Neulog, USA) and a syringe for 
pressure measurement and control, respectively. Placing the bioresorbable sensor inside the 
container, partially filled with artificial cerebrospinal fluid (ACSF, pH 7.4; Ecocyte BioSciences, 
USA), followed by connnecting the wires to a power supply (Vs = 2.5 V) and a digital 
multimeter (Fig. 2.9) prepared the system for testing. Collecting the voltage response of the 
bioresorbable device and pressures from the commercial device simultaneously, while varying 
the fluid pressure by moving the plunger of the syringe in and out, yielded a calibration curve 
over the range of pressures relevant to intracranial monitoring (0-70 mmHg, Fig. 2.10a).  
Evaluation of the hydrolysis kinetics. Measurements by spectroscopic reflectometry 
(MProbe; Semiconsoft, Inc., USA) defined changes in thicknesses of films of thermal and e-
beam SiO2 (t-SiO2 and eb-SiO2). Profilometry (Alpha Step) revealed the thicknesses of square 
dots (50 um x 50 um) of amorphous silica adhesion interlayer formed on t-SiO2 wafers (Fig. 
2.11). Each sample had a lateral size of ~1 cm x 1 cm, with coatings of t-SiO2 on the side and 
bottom surfaces formed by thermal oxidation. The experiments involved placing the sample in a 
screw cap plastic bottle filled with ~50 mL of ACSF solution, storing the bottle in an oven 
(Fisher Scientific, USA) to maintain the solution temperature near 37 oC, and monitoring the 
temperature throughout the experiment using a digital thermometer probe (DTP482; CDN, USA) 
penetrating through the plastic cap. Rinsing the sample with deionized water, drying, measuring 
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the thickness, and placing back in the solution (renewed every 4 days), repeatedly, yielded the 
dissolution rates.  
Accelerated soaking tests. Soaking the device in phosphate buffered saline (PBS, pH 7.4; 
Sigma-Aldrich, USA) at 95oC for some time, rinsing with deionized water, drying, and analyzing 
under an optical microscope yielded images of a bioresorbable sensor through various stages of 
accelerated dissolution. Similarly, evaluation of the change in the pressure sensitivity of the 
device throughout a process of thinning of the t-SiO2 encapsulation layer involved soaking the 
device in PBS at 95oC for 30 minutes, rinsing with deionized water, drying, calibrating against 
the commercial pressure sensor, and placing back in the PBS. The dissolution chamber 
comprised of a screw cap plastic bottle, installed with a penetrating thermometer probe and kept 
in a heated oven.  
Evaluation of the biodistribution, hematology, and blood chemistry of mice. Overnight 
ultraviolet radiation sterilized miniaturized bioresorbable sensors (size: 750 µm x 750 µm x 11 
µm; weight ~12 µg) without t-SiO2 encapsulation prior to device implantation. The procedures 
involved anaesthetizing a female CD-1 mouse (Charles River, USA) with isoflurane gas, fixing 
the head in a stereotaxic frame, forming a craniectomy defect using a drill, implanting the sensor 
into the intracranial cavity, sealing the defect with a drop of biodegradable tissue adhesive 
(TissueSeal, USA), and suturing the scalp. Daily monitoring and weighing of the mice ensured 
their normal stress and moribund conditions. Computed tomography scans carried out every 
week tracked the size and location of the implanted device. Euthanization of 1-2 mice at weeks 1, 
3, and 5 after device implantation enabled extraction of blood and explantation of organs 
including liver, spleen, heart, kidney, brain, and lung. Charles River Laboratory (Boston, MA) 
conducted complete blood count and blood chemistry tests on the blood samples collected in K-
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EDTA tubes and gel tubes, respectively. Weighing, splitting the explanted organs in half, and 
storing the halves in pre-weighed 15 mL conical metal-free tubes in -20 oC fridge and in 10 % 
buffered formalin in 50 mL conical tubes prepared tissue samples for biodistribution and 
histology studies, respectively. Dissolving the tissues by adding 1.5 mL nitric acid and 0.35 mL 
hydrogen peroxide to each tube, keeping the tubes in 65oC water bath for 5 hours, diluting the 
dissolved tissue solutions 1:20 by adding Milli-Q water (MilliporeSigma, USA), and analyzing 
by inductively coupled plasma optical emission spectrometry (ICP-OES) yielded the 
concentrations of Si in the tissues 1, 3, and 5 weeks after implantation to demonstrate 
biodistribution and biodegradability of dissolved silicon.  
Evaluation in animal models. All procedures of the animal study followed the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health. The Institutional Animal Care and Use Committee (IACUC) of Washington 
University in St Louis (protocol number 20170189) approved the protocol. Male Lewis rats 
weighing 250–350 g (Charles River, Wilmington, MA) received subcutaneous injections of 
buprenorphine hydrochloride (0.05 mg kg−1; Reckitt Benckiser Healthcare Ltd, USA) for pain 
management, and of ampicillin (50 mg kg−1; Sage Pharmaceuticals, USA) to prevent infection at 
the implantation site before the surgical process. The surgical procedures involved anaesthetizing 
the rat with isoflurane gas, holding the head in a stereotaxic frame, opening a craniectomy and 
dura, implanting the bioresorbable sensor on the cortical surface, and sealing the craniectomy 
with a PLGA sheet (~10 μm thick) and biodegradable glue (TissueSeal, USA). A clinical 
intracranial pressure monitor (Integra LifeSciences, USA) or a commercial thermistor (Digi-Key, 
USA) implanted in a nearby craniectomy enabled comparison testing to demonstrate the 
accuracy of the pressure and temperature measurements by the bioresorbable sensor, respectively. 
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Biodegradable glue sealed the opening for commercial sensor after testing. A plastic chamber 
with cap (Pinnacle Technology, USA), fixed on the skull by dental cement (Fusio™ Liquid 
Dentin; Pentron, USA), stored and protected the implanted bioresorbable sensor and its electrical 
connectors for subsequent tests.  
Evaluation of the MRI compatibility. The set-up consisted of a bioresorbable sensor and 
two fiber optic temperature probes (Luxtron 812 Fluoroptic Thermometer; LumaSense 
Technologies, USA), one placed near the sensor and the other distant, sandwiched between brain 
phantom slabs (True Phantom Solutions, Inc., Canada). A 3 Tesla Siemens Magnetom Prisma 
MRI scanner performed a high-SAR (Specific Adsorption Rate, or RF deposition) turbo spin 
echo (TSE) scan (repetition time (TR) = 6290.0 ms, echo time (TE) = 99 ms, 14 slices, 
thickness= 4 mm, flip angle = 180⁰, field of view = 230 × 230 mm) continuously for 20 minutes.  
Calculation of the Gauge Factor. The gauge factor (G) of the silicon nanomembrane 
strain gauge (Si NM SG) can be estimated by the following equation35: 
 
where ∆R is the change in resistance of the SG due to piezoresistivity of silicon at elevated 
pressures, R0 is the resistance of the SG at atmospheric pressure, and ɛ is the average strain in the 
SG.  
Three-dimensional finite element analysis (3D-FEA) using commercial software 
(ABAQUS) can reveal the average strain within the SG under pressure load ranging from 0 to 40 
mmHg (Fig. 2.4a) based on quadrilateral shell element S4R for the diaphragm and clamped edge 
boundary conditions8. The resistance change ∆R with respect to applied pressure can be obtained 
experimentally. The base resistance R0 of the SG lying on the diaphragm is estimated by FEA to 
be ~38.9 % of the resistance measured across the metal contact pads based on SG design, 
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assuming uniform doping concentration in the silicon nanomembrane. The slope of a plot of 
∆R/R0 versus ɛ yields a gauge factor of –20.9 (Fig. 2.4b).  
The gauge factor can also be calculated analytically by the following equation36:  
 
where α is a correction coefficient for different doping concentrations37, π is the piezoresistive 
coefficient for n-type monocrystalline silicon, and E represents Young’s modulus. The calculated 








Figure 2.1 Procedures for fabricating inorganic bioresorbable pressure sensors. a, Steps for 
fabricating piezoresistive sensors based on silicon nanomembranes (Si NMs, pink) on a silicon-
on-insulator (SOI) wafer, SOI-A (1). Reactive ion etching to form an array of vent holes through 
the wafer (2). Reactive ion etching to form a trench (top white) on a separate SOI wafer, SOI-B 
(3). Aligned bonding of SOI-A and SOI-B using a thin film of PDMS (beige) as an adhesion 
interlayer (4). Calcination of the PDMS to yield amorphous silica (orange) by heating in a 
furnace (5). Release of gaseous products (CO2 and H2O) through vent holes in SOI-A.  Reactive 
ion etching to eliminate the silicon wafer of SOI-A (6). Wet etching of the buried oxide using 
buffered oxide etchant (BOE) to yield a layer of SiO2 (green) with desired thickness and to 
expose regions for electrical contacts (7). Reactive ion etching to eliminate the silicon wafer and  
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Fig. 2.1 (cont.) the buried oxide of SOI-B (8). B, Photograph of a bioresorbable pressure sensor 
next to the tip of a ball point pen. c, Optical micrograph of the sensor (left). Two Si NM 
structures that extend partially over the trench on a flexible diaphragm define strain gauges (SGs, 
blue) with piezoresistive responses. A pair of Si NM sensors on regions adjacent to the trench 
define temperature gauges (TGs, red) via their temperature-dependent resistance. Four gauges 
combine to form a Wheatstone bridge circuit (right) that compensates temperature induced 
variations in the piezoresistivity of the SGs. d, Optical micrograph of SGs embedded in a 
diaphragm. Two boundary lines (grey area, no silicon) isolate the SGs (pink area, silicon) from 
the surrounding Si NM. Thermal SiO2 (t-SiO2), Si NM, and SiO2 deposited by electron beam 
evaporation (eb-SiO2) define the flexible diaphragm that spans over the square trench. e, Three-
dimensional finite element analysis (3D-FEA) results for the distribution of principal strains 
(left) and vertical displacements (right) of the diaphragm for an external pressure of 40 mmHg 
above atmospheric. f, Responses of a bioresorbable pressure sensor (red, Vs = 2.5V) and a 
commercial sensor (blue) to time-varying pressures over a range relevant to variations in 









Figure 2.2 a, Scanning electron microscope and b, atomic force microscope images of the 










Figure 2.3 a, Silicon NMR spectroscopy (29Si DPMAS) and b, electron dispersive spectroscopy 
(EDS) measurements of amorphous silica powder obtained from PDMS calcination followed by 






Figure 2.4 a, Three-dimensional finite element analysis (3D-FEA) of the average strain within a 
strain gauge (SG) due to applied pressure. b, Resistance responses of the SG with simulated 
average strain. The gauge factor (slope) is -20.9. c, Calibration of the resistance of a 













Figure 2.5 Secondary ion mass spectrometry (SIMS) profile of phosphorus distributed 






Figure 2.6 a, Optical micrograph and b, calibration curve of a bioresorbable sensor with a thin Si 
NM (~50 nm), large diaphragm area (500 μm x 500 μm), and serpentine strain gauge. The sensor 












Figure 2.7 Calibration of the resistance of a bioresorbable temperature gauge (TG). The 







Figure 2.8 Pressure sensitivity of a bioresorbable sensor measured at different temperatures 
within a range relevant for intracranial temperature (33-40 oC). Maximum deviation in measured 













Figure 2.9 a, Photograph of the test set-up for in vitro assessment of bioresorbable intracranial 









Figure 2.10 a, Calibration of the voltage responses of a bioresorbable sensor with pressures 
measured by commercial sensor. b, Noise floor in the response of the bioresorbable sensor (red), 
evaluated as the difference between pressures measured by the bioresorbable and commercial 
devices exposed to time-varying pressure. Pressures recorded by the commercial sensor (blue), 












Figure 2.11 a, Calibration curves for a bioresorbable pressure sensor obtained throughout a 22-
day period of in vitro operation in ACSF at T = 37oC (left). Pressure sensitivity as a function of 





Figure 2.12 Kinetics of dissolution of a bioresorbable pressure sensor. a, Measured changes in 
thickness as a function of time of immersion of t-SiO2 (left), eb-SiO2 (middle), and amorphous 
silica (obtained from calcination of PDMS, right) in artificial cerebrospinal fluid (ACSF, pH 7.4) 
at 37oC. The dissolution rates are 0.11 ± 0.01, 13.6 ± 1.6, and 129 ± 9 nm/day, respectively. b, 
Schematic illustration of the in vitro dissolution experiment set-up. c, Optical micrographs at 
various stages of accelerated dissolution of a bioresorbable pressure sensor due to immersion in 
phosphate buffered saline (PBS, pH 7.4) at 95oC. d, Voltage response of a sensor with t-SiO2 
encapsulation (~10 nm) and comparison to a commercial device at various times after immersion 
in PBS at 95oC (left), with corresponding responsitivities as a function of time (middle). The data 
indicate two-stage kinetics in function, involving stable operation for several hours, defined by 
dissolution of thermal SiO2 encapsulation layer, followed by rapid degradation due to formation 








Figure 2.13 a, Fabrication steps and b, optical micrograph of an array of square patterns of silica 







Figure 2.14 In vivo measurements of elemental biodistribution and biocompatibility of 
bioresorbable devices throughout their functional lifetimes and beyond. a) In vivo biodistribution 
of products of dissolution of bioresorbable pressure sensors (size: 750 µm x 750 µm x 10 µm; 
weight ~12 µg; no t-SiO2 encapsulation) implanted within the intracranial space of mice (n = 1 
or 2), with comparisons to control animals (n = 2). A drop of biodegradable tissue adhesive  
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Fig. 2.14 (cont.) (TissueSeal, USA) seals the craniectomy defect after implantation. Inductively 
coupled plasma optical emission spectrometry (ICP-OES) determines concentrations of silicon in 
organs explanted at 1, 3, and 5 weeks post implantation.  High concentrations of silicon in spleen, 
heart, and lung tissues in the first week after implantation decrease gradually to normal levels. b) 
Computed tomography (CT) scans of a mouse brain after 5 weeks. Cartoon illustrations and CT 
images 5 weeks post implant of the sagittal (left), coronal (middle), and axial (right) planes show 
the locations of the craniectomy and a sensor near the surface of the brain fixed at a tilted angle. 
c, d) Results of c) complete blood count test and d) blood chemistry test for the mice in a.  No 
significant differences from control animals can be found for both tests.  Control data provided 
by the mouse supplier (Charles River, gray) or collected from 22-24 mice acquired from two 
batches within 2 months’ span (cyan).  Red error bars indicate 95% confidence intervals; black 
error bars indicate S.E. Abbreviations include, WBC: white blood cell, RBC: red blood cell, 
HGB: blood hemoglobin level, HCT: hematocrit level, PLT: platelet count in blood, ALT: 
alanine aminotransferase, CHOL: cholesterol, TRIG: triglycerides, PHOS: phosphorus, BUN: 
urea nitrogen, GLU: glucose, CAL: calcium, TP: total protein, ALB: albumin. e) 
Immunohistochemistry of brain, spleen, heart, and kidney tissues of a control mouse and a 
mouse implanted with a bioresorbable sensor 5 weeks post implantation, showing no notable 





Figure 2.15 Results for complete blood count (CBC) tests of mice implanted with bioresorbable 
intracranial pressure sensors. Abbreviations include, NE: neutrophil, LY: lymphocyte, MO: 
monocyte, EO: eosinophil, BA: basophil, MCV: mean corpuscular volume, MCH: mean 
corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, RDW: red cell 








Figure 2.16 Results from blood chemistry tests of mice implanted with bioresorbable 
intracranial pressure sensors. Abbreviations include, GGT: gamma-glutamyl transferase, CREA: 





Figure 2.17 Changes in body weights of mice implanted with bioresorbable pressure sensors (n 











Figure 2.18 Immunohistochemistry of lung and liver tissues of a control mouse and a mouse 





Figure 2.19 Acute and chronic monitoring of intracranial temperature and pressure in rats using 
bioresorbable sensors. a, Photograph of a bioresorbable ICP sensor implanted in a rat. Image of a 
sensor mounted on a thin film of poly(lactide-co-glycolide) (PLGA, ~10 um thick; inset), placed 
in an intracranial cavity on the right hemisphere after exposure by craniectomy.  Biodegradable 
glue bonds the edges of the film to the surrounding skull and seals the cavity.  Wired connection 
to a digital multimeter allows data acquisition from the sensor. A clinical ICP monitor probe 
inserted in the same hemisphere of the brain serves as reference. b, In vivo recordings of 
intracranial temperature (ICT) of a rat as a function of time. Both bioresorbable (red) and 
commercial (blue) devices capture gradual increase (left) and decrease (right) in ICT caused by 
application of heating blanket/ice pack. c, d, e, In vivo monitoring of variations in ICP due to c, 
contracting and releasing rat’s flank, d, laying in Trendelenburg (30o head-down; increases ICP) 
and reverse Trendelenburg (30o head-up; decreases ICP) positions, e, and infusing Mannitol, 
which decreases ICP, in the saphenous vein, as a function of time by both bioresorbable (red) 
and commercial (blue) sensors. f, In vivo recordings of ICP as a function of time on days 1, 8, 18, 
and 25 post implantation. About 10 mmHg variations in ICP are induced by contracting and 
releasing the intraperitoneal (body) cavity. Recordings on day 25 show ~3 mmHg negative drift 





Figure 2.20 Photograph of a rat mounted with a plastic hat for protection of the implanted sensor 













Figure 2.21 Magnetic resonance imaging (MRI) compatibility of a bioresorbable sensor placed 
in a brain phantom, designed to imitate the conductivity and dielectric constant of brain tissue. 
Photograph of a bioresorbable sensor and two fiber-optic temperature probes (one near and the 
other distant from the sensor) placed in between two slabs of the phantom (left). Recordings of 
the difference in temperatures measured by the two probes throughout a 20-minute, high-specific 





1 Jiang, G. Design challenges of implantable pressure monitoring system. Frontiers in 
Neuroscience 4 (2010). 
2 Yu, L., Kim, B. & Meng, E. Chronically Implanted Pressure Sensors: Challenges and State 
of the Field. Sensors 14, 20620 (2014). 
3 Sit, A. J. Continuous Monitoring of Intraocular Pressure: Rationale and Progress Toward A 
Clinical Device. Journal of Glaucoma 18, 272-279 (2009). 
4 Boutry, C. M. et al. Towards biodegradable wireless implants. Philosophical Transactions of 
the Royal Society A: Mathematical, Physical and Engineering Sciences 370, 2418-2432 
(2012). 
5 Chamis, A. L. et al. Staphylococcus aureus Bacteremia in Patients With Permanent 
Pacemakers or Implantable Cardioverter-Defibrillators. Circulation 104, 1029-1033, (2001). 
6 Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Bacterial biofilms: from the Natural 
environment to infectious diseases. Nature Reviews Microbiology 2, 95, (2004). 
7 Polikov, V. S., Tresco, P. A. & Reichert, W. M. Response of brain tissue to chronically 
implanted neural electrodes. Journal of Neuroscience Methods 148, 1-18 (2005). 
8 Kang, S.-K. et al. Bioresorbable silicon electronic sensors for the brain. Nature 530, 71 
(2016). 
9 Luo, M., Martinez, A. W., Song, C., Herrault, F. & Allen, M. G. A Microfabricated Wireless 
RF Pressure Sensor Made Completely of Biodegradable Materials. Journal of 
Microelectromechanical Systems 23, 4-13 (2014). 
10 Hwang, S.-W. et al. Biodegradable Elastomers and Silicon Nanomembranes/Nanoribbons for 
Stretchable, Transient Electronics, and Biosensors. Nano Letters 15, 2801-2808 (2015). 
106 
 
11 Yu, K. J. et al. Bioresorbable silicon electronics for transient spatiotemporal mapping of 
electrical activity from the cerebral cortex. Nature Materials 15, 782 (2016). 
12 Lee, Y. K. et al. Dissolution of Monocrystalline Silicon Nanomembranes and Their Use as 
Encapsulation Layers and Electrical Interfaces in Water-Soluble Electronics. ACS Nano 11, 
12562-12572 (2017). 
13 Lee, G. et al. Fully Biodegradable Microsupercapacitor for Power Storage in Transient 
Electronics. Advanced Energy Materials 7 (2017). 
14 Lee, C. H. et al. Wireless Microfluidic Systems for Programmed, Functional Transformation 
of Transient Electronic Devices. Advanced Functional Materials 25, 5100-5106 (2015). 
15 Tao, H. et al. Silk-based resorbable electronic devices for remotely controlled therapy and in 
vivo infection abatement. Proceedings of the National Academy of Sciences 111, 17385-
17389 (2014). 
16 Hwang, S.-W. et al. A Physically Transient Form of Silicon Electronics. Science 337, 1640-
1644 (2012). 
17 Hwang, S.-W. et al. High-Performance Biodegradable/Transient Electronics on 
Biodegradable Polymers. Advanced Materials 26, 3905-3911 (2014). 
18 Kang, S.-K. et al. Dissolution Behaviors and Applications of Silicon Oxides and Nitrides in 
Transient Electronics. Advanced Functional Materials 24, 4427-4434 (2014). 
19 Kang, S.-K. et al. Biodegradable Thin Metal Foils and Spin-On Glass Materials for Transient 
Electronics. Advanced Functional Materials 25, 1789-1797 (2015). 
20 Fang, H. et al. Ultrathin, transferred layers of thermally grown silicon dioxide as biofluid 
barriers for biointegrated flexible electronic systems. Proceedings of the National Academy 
of Sciences 113, 11682-11687 (2016). 
107 
 
21 Lee, Y. K. et al. Kinetics and Chemistry of Hydrolysis of Ultrathin, Thermally Grown Layers 
of Silicon Oxide as Biofluid Barriers in Flexible Electronic Systems. ACS Applied Materials 
& Interfaces 9, 42633-42638 (2017). 
22 Haddad, S. H. & Arabi, Y. M. Critical care management of severe traumatic brain injury in 
adults. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 20, 12 
(2012). 
23 Camino, G., Lomakin, S. M. & Lazzari, M. Polydimethylsiloxane thermal degradation Part 1. 
Kinetic aspects. Polymer 42, 2395-2402 (2001). 
24 Wang, Q., Ding, J. & Wang, W. Fabrication and temperature coefficient compensation 
technology of low cost high temperature pressure sensor. Sensors and Actuators A: Physical 
120, 468-473 (2005). 
25 Kanda, Y. A graphical representation of the piezoresistance coefficients in silicon. IEEE 
Transactions on Electron Devices 29, 64-70 (1982). 
26 Lund, E. & Finstad, T. G. Temperature and Doping Dependency of Piezoresistivity in p-type 
Silicon. MRS Proceedings 657 (2000). 
27 Norton, P. & Brandt, J. Temperature coefficient of resistance for p- and n-type silicon. Solid-
State Electronics 21, 969-974 (1978). 
28 Brain Trauma, F. et al. Guidelines for the management of severe traumatic brain injury. VI. 
Indications for intracranial pressure monitoring. J Neurotrauma 24 Suppl 1, S37-44 (2007). 
29 Post craniotomy subdural pressure monitoring kit. Model 110-4G, in San Diego, CA: Integra 
NeuroSciences (2010). 
30 Johanson, C. E. et al. Multiplicity of cerebrospinal fluid functions: New challenges in health 
and disease. Cerebrospinal Fluid Research 5, 10 (2008). 
108 
 
31 Moghimi, S. M. & Patel, H. M. Serum-mediated recognition of liposomes by phagocytic 
cells of the reticuloendothelial system – The concept of tissue specificity. Advanced Drug 
Delivery Reviews 32, 45-60 (1998). 
32 Gelabert-González, M. et al. The Camino intracranial pressure device in clinical practice. 
Assessment in a 1000 cases. Acta Neurochirurgica 148, 435-441 (2006). 
33 Martínez-Mañas, R. M., Santamarta, D., de Campos, J. M. & Ferrer, E. Camino® intracranial 
pressure monitor: prospective study of accuracy and complications. Journal of Neurology, 
Neurosurgery &amp;amp; Psychiatry 69, 82 (2000). 
34 Zacchetti, L., Magnoni, S., Di Corte, F., Zanier, E. R. & Stocchetti, N. Accuracy of 
intracranial pressure monitoring: systematic review and meta-analysis. Critical Care 19, 420 
(2015). 
35 Maluf, N. & Williams, K. Introduction to Microelectromechanical Systems Engineering.  
(Artech House, 2004). 
36 Liu, C. Foundations of MEMS.  214-215 (Prentice-Hall, 2006). 
37 Lund, E. & Finstad, T. G. Temperature and Doping Dependency of Piezoresistivity in p-type 





CHAPTER 3: BIORESORBABLE OPTICAL SENSORS AND WAVEGUIDES 
 
3.1 Introduction 
 Bioresorbable sensors, an emerging class of technology in which the constituent materials 
disappear completely in a controlled fashion within the body, provide basis for novel implantable 
devices that can avoid patient distress and complications associated with surgical removal 
procedures, as well as infection via biofilm colonization along percutaneous wires, problems that 
are commonly associated with standard permanent electronic hardware3,4,6-8,10. Optical sensors, 
based on changes in intensity or resonance frequency of guided light rather than electrical 
parameters like voltage or current, offer several important advantages over electronic analogs, 
such as compatibility with magnetic resonance imaging (MRI), which is frequently used in 
patients that undergo surgery and are primary targets for sensor implants, but could cause heating 
or displacement of electronic implants24; they also offer safety from potential tissue damage due 
to normal or leakage current flows25.  
 Here, we demonstrate materials, design, and fabrication strategies for bioresorbable 
optical pressure and temperature sensors. Two types of optical pressure sensors based on Fabry-
Perot interferometry and photonic crystal microcavities both demonstrate good pressure 
sensitivity with linear responses to pressure variation, verified by simulation as well as in vitro 
and in vivo experiments. Accelerated dissolution tests in hot phosphate buffered saline solutions 





 Schematic illustration of the fabrication procedures for bioresorbable Fabry-Perot (FP) 
pressure sensors appear in Fig. 3.1. The process began with solid-state diffusion of phosphorous 
at 950oC on a mechanically back-grinded silicon-on-insulator (SOI-A) wafer (top Si ~250 nm, 
buried SiO2 ~1 μm, Si wafer ~100 μm; SOITEC, France) to reach doping concentration of ~1020 
cm-3. Fabrication of silicon trench involved patterning and deep reactive ion etching (ICP-DRIE) 
of an array of square patterns (area: 250 μm x 250 μm) on a separate SOI wafer (SOI-B, top Si 
~15 μm, buried SiO2 ~600 nm, Si wafer ~85 μm; University Wafer, USA). Removing the Si 
wafer of SOI-B by ICP-DRIE, wet etching in a buffered oxide etchant (BOE, 6:1; Transene 
Company Inc., USA) to remove the exposed buried SiO2, and cleaning the sample of residual 
photoresist and crystal bond (used in ICP-DRIE process) via a descum process (March RIE) 
yielded 15 μm-thick slab of monocrystalline silicon with array of square holes (trenches).  
Wafer bonding two wafers of SOI-A with a 15 μm-thick silicon trench involved spin-
coating a layer of diluted poly(dimethylsiloxane) (PDMS, part A/part B/hexane = 10:1:100, 
Sylgard 184; Dow Corning, USA) at a speed of 3000 rpm for 30 seconds on each SOI-A, 
followed by sandwiching the silicon trench between the two SOI-A wafers. Pressing the wafers 
together in a steel vise (Toomaker’s vise; Tormach, Inc., USA) and placing the vise in a 70 oC 
convection oven for 2 hours fully cured the PDMS, bonding the wafers. Heating the vise in a 
furnace, by raising the temperature to 550oC over 2 hours and keeping there for 2 more hours, 
converted the PDMS adhesion layer to amorphous silica. Then, ICP-DRIE removed the top and 
bottom Si wafers of SOI-A of the bonded sample to expose buried oxide on both top and bottom 
sides. Wet etching in a buffered oxide etchant (BOE) removed the buried oxides, exposing Si 
NM diaphragms.  
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Integrating the resulting structure with a single-mode optical fiber (core diameter ~9 μm, 
cladding ~125 μm), connected with a tunable laser source (Agilent 8163B1; Agilent 
Technologies, USA), polarization-maintaining (PM) fiber, single-mode (SM) fiber and circulator, 
and photodetector completed the optical sensing system (Fig. 3.2). Procedures for fiber-sensor 
alignment involved positioning the SM fiber close to a flat surface of the device on regions 
surrounding the diaphragm, tuning fiber angle for the best FP profile, moving the fiber laterally 
for alignment on the diaphragm, verifying silicon and air FP resonances, applying UV-curable 
glue, and curing by exposing UV light. Connecting the laser source to Port 1 of the circulator and 
the sensor to Port 2 allowed monitoring of peak shift in the return loss spectrum. The returned 
optical intensity at Port 3 characterized the FP interference in the sensor’s air cavity of which the 
thickness is subjected to the ambient pressure.  
Fabrication of bioresorbable FP temperature sensor involved preparing a 15 μm-thick 
slab of monocrystalline silicon by removing Si wafer and buried oxide of SOI-B wafer by ICP-
DRIE and wet etching in BOE, followed by integrating the resulting structure with a SM fiber.  
Fabrication of bioresorbable photonic microcavity (PC) pressure sensor involved 
fabrication of the cavities on SOI-A wafer using electron-beam lithography, dry etching 
alignment marks through the wafer using ICP-DRIE process (to allow alignment of cavities over 
the trench during wafer bonding step), wafer bonding with silicon trench (dimensions: 250 µm x 
250 µm x 10 µm) fabricated on SOI-B wafer using PDMS followed by calcination process, 
removal of Si wafers and thinning of buried oxides of SOI-A and SOI-B using ICP-DRIE 





3.3 Results and Discussion 
A fully bioresorbable Fabry-Perot (FP) pressure sensor consists of two nanomembranes 
of highly Phosphorous-doped (doping concentration ~1020 cm-3) monocrystalline silicon that 
serve as pressure-sensitive flexible membranes that are bonded to a 15 µm-thick Si trench 
structure by adhesion interlayers of amorphous silica (Fig. 3.3a). Fabrication process involves 
wafer bonding of silicon-on-insulator (SOI) wafers of two different top silicon thicknesses (250 
nm and 15 µm) using poly(dimethylsiloxane) (PDMS), followed by calcination at temperatures 
at 550 °C to convert PDMS to amorphous silica, and back-etching of Si wafers by deep reactive 
ion etching processes followed by wet etching in buffered oxide etchant to remove exposed 
buried oxides. Integrating the structure with single-mode (SM) optical fiber, connected with 
tunable laser source, circulator, polarization-maintaining fiber, and photodetector, allows 
pressure readout (Fig. 3.3b). Increase in surrounding air or fluid pressure pushes the membrane 
downward, which reduces the thickness of the air cavity in between the silicon membranes, 
leading to blue shift of the FP resonance signal, as observed from both simulation and 
experimental results (Figs. 3.3c and d).  
Figure 3.4 shows results of mechanical and optical simulations, based on three-
dimensional finite element analysis (3D-FEA) using ABAQUS software, which determines the 
deformation of the diaphragm at different surrounding pressures (Fig. 3.4a), and electromagnetic 
wave analysis using S4 software, which determines shift in the peak of the optical spectrum of 
the reflected laser at different center locations (Fig. 3.4b), respectively. As the pressure increases, 
the thickness of air layer underneath the diaphragm decreases. The destructive interference 
wavelength in the air cavity, indicated by the peaks in the return loss, shift to smaller wavelength 
due to the shortening in the light path length. The monotonic correlation of the ambient pressure 
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and the return loss peak provides an accurate measurement with high sensitivity at optimized 
design parameters.  
Device structures and in vitro calibration curve for bioresorbable FP temperature sensor 
appear in Figure 3.5. The sensor consists of a 15 µm-thick slab of silicon connected with a SM 
optical fiber (Fig. 3.5a), and functions also as a FP interferometer, for which the peak 
wavelength of the optical spectrum red shifts linearly at a slope of 47.9 pm/oC with respect to 
changes in surrounding temperature due to change in refractive index (thermo-optics effect; Fig. 
3.5b).  
Temperature sensing is critical in pressure measurement in the use of FP pressure sensor, 
as temperature affects the sensor performance significantly. Results of in vitro calibration of the 
pressure sensor indicate that the baseline (peak wavelength under atmospheric pressure) shifts 
linearly as a function of temperature with a slope of 11.9 nm/oC (Fig. 3.6b). This is caused by 
expansion of the volume of air inside the cavity with rising temperature, which increases the 
length of air layer and affects the FP resonance signal. Figure 3.6c shows the pressure sensitivity 
(shift in peak wavelength per mmHg change in pressure) measured at different temperatures. No 
obvious trend is found, and the maximum error in sensitivity is ~7%.  
In vivo monitoring of acute variations in intracranial pressure (ICP) and temperature 
(ICT) using bioresorbable FP sensors appears in Figure 3.7. The procedures for implanting the 
device as shown in Figure 3.7a includes opening a small craniectomy (~3 mm x 3 mm) on the 
skull and piercing open the dura mater, placing the sensor inside with diaphragm facing 
downwards, covering the top of the sensor with a biopolymer film, and sealing the gap between 
the cover and the skull using biodegradable glue.  
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A clinical ICP monitor probe implanted near the bioresorbable device allows calibration 
of the sensor in vivo (Fig. 3.7b and c), which involves squeezing rat’s flank until the readings on 
clinical monitor stabilizes then collecting the optical spectrum from bioresorbable device. The 
design of the pressure sensor tested in the study illustrated in Figure 3.7a and b consisted of ~100 
µm-thick air cavity and diaphragm consisting of 250 nm Si / ~1 µm SiO2, which led to 
significantly reduced pressure sensitivity of -10.9 nm/mmHg. Temperature sensor calibration can 
be done in similar ways to yield a temperature responsivity of ~98 pm/oC, which is within the 
observed ranges for fabricated devices (Fig. 3.7c and d).  
Figure 3.8 illustrates another type of bioresorbable optical pressure sensor that relies on 
shifts in the returned resonance spectrum from an array of photonic crystal (PC) microcavities 
(diameter ~85 nm, separation between cavities ~1 µm) fabricated on the diaphragm. Changes in 
surrounding pressure deforms the diaphragm, which affects the distance between the PC cavities 
on the diaphragm, leading to shifts in the optical spectrum from reflected laser. Figure 3.8a 
illustrates materials and design of the bioresorbable PC pressure sensor, with light delivered via 
free-space detection mechanism from a distant laser. The design of the PC cavities located on the 
diaphragm are highlighted in the scanning electron microscopy (SEM) image in Figure 3.8b, an 
image obtained while the device is on the SOI wafer, prior to wafer bonding and back-etching 
procedures. Optical micrograph of the active region appears in Figure 3.8c. PC cavity array 
(outer square, area: 300 µm x 300 µm) sits over the air cavity (inner square, area: 250 µm x 250 
µm). 
For PC pressure sensor, the resonance spectrum red shifts in response to increasing 
pressure, as shown in Figure 3.8d. The pressure sensitivity is 1.9 pm/mmHg, which is 
significantly smaller compared to that of a FP device, for reasons of ease with which the 
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membrane can move vertically as opposed to expand laterally. Figure 3.8e shows optical set-up 
used for in vitro sensor calibration. While PC- and FP-based bioresorbable pressure sensors are 
both feasible, FP devices have advantages of simpler fabrication procedures (does not require e-
beam lithography, align mark etching steps) and higher responsivity to pressure. Light delivery 
and collection through integrated optical fiber also has advantages over free-space detection 
method used here as it allows more freedom of movement for the sensor (no need to align laser 
onto diaphragm for measurement) and also is unaffected by concerns of loss of light intensity 
when the light travels through water, which makes collecting signals from PC devices deployed 
in watery environments of the body difficult.  
Complete disintegration in biofluids into biologically benign end products is key 
characteristic of bioresorbable implants. Layers of silicon and silicon dioxide, which make up the 
FP and PC devices demonstrated in this study, are known to degrade in water via hydrolysis to 
yield silicic acid Si(OH)4. Figure 3.9 shows the set-up (left) and optical micrographs (right) of a 
FP pressure sensor collected at various stages of accelerated dissolution by immersing in PBS at 
95 oC. Highly doped silicon nanomembrane dissolve away within 3 hours, followed by 
amorphous silica bonding layer in 6 hours, followed by the 10 µm-thick silicon trench within 60 
hours. Complete disappearance yields thermal SiO2 substrate with a slight relief feature.  
Figure 3.10 shows effects of silicon nanomembrane dissolution on PC resonance signals 
of a PC cavity device fabricated on SOI wafer. Figure 3.10a shows SEM images of the cavities 
before and after immersion in PBS (pH ~7.4, 85oC) for 30 minutes, indicating rough surface 
profile. The resonance spectrum also blue shifts linearly, matching the decrease in silicon 





 Bioresorbable optical implants for intracranial pressure and temperature sensing and light 
delivery have potential for wide clinical application replacing conventional electronic implants 
that are susceptible to electromagnetic interference and normal/leakage current flow that may 
cause local thermal damage to the biological structure. In vitro and in vivo calibration results 
verify the accuracy of these sensors. Accelerated dissolution experiments demonstrate transience 
of the sensors, waveguides, and polymers. Future studies will aim to identify long-term stability 
of optical pressure and temperature monitoring in vivo and develop strategies to integrate 
bioresorbable optical sensors with waveguides/fibers to build fully bioresorbable optical sensing 
platform. The device structures and materials studied here may also serve as platform for 









Figure 3.1 Fabrication procedures for bioresorbable Fabry-Perot pressure sensors integrated with 







Figure 3.2 Optical set-up for bioresorbable Fabry-Perot pressure and temperature sensors 
integrated with commercial optical fibers. Consists of tunable laser source, polarization-
maintaining (PM) optical fiber, single-mode (SM) optical fiber and circulator, and photodetector. 





Figure 3.3 Bioresorbable Fabry-Perot pressure sensor integrated with single-mode optical fiber. 
a, Schematic illustration of the pressure sensor integrated with optical fiber via UV-curable glue. 
b, Photograph of the sensor. Inset: optical micrograph of the sensing silicon nanomembrane 
diaphragm. c, Simulated return spectrum of the Si pressure sensor as the air layer thickness 
changes by S4 software. d, Experimentally obtained (at constant surrounding temperature) 





Figure 3.4 Mechanical and optical simulation of bioreosrbable Fabry-Perot pressure sensor. a, 
Simulation of diaphragm deflection at various pressures based on three-dimensional finite 
element analysis (3D-FEA) using ABAQUS software. b, Simulation of the peak wavelength 
extracted from the Fabry-Perot resonance return loss spectrum at different membrane 





Figure 3.5 Bioresorbable Fabry-Perot temperature sensor based on thermo-optics effect of 
silicon. a, Schematic illustration of the sensor, consisting of a 15 µm-thick slab of 
monocrystalline silicon, aligned and bonded with an optical fiber. b, Fabry-Perot resonance 






Figure 3.6 In vitro calibration of bioresorbable pressure sensor in phosphate buffered saline 
(PBS, pH ~7.4) at different temperatures. a, Resonance spectra collected at various sets of 
pressures and temperatures within PBS solution. b, Peak wavelength of the sensor under 
atmospheric pressure at various temperatures, indicating red shift of the baseline at linear slope 
of 11.9 nm/oC. c, Pressure sensitivity (shift in peak wavelength as a function of pressure) at 





Figure 3.7 In vivo monitoring of intracranial pressure (ICP) and temperature (ICT) using 
bioresorbable optical sensors. a, Photograph of bioresorbable and commercial ICP sensors 
(reference) implanted in the subdural space. b, Fabry-Perot resonance signals and pressures 
collected by both devices while raising ICP by squeezing the flank. The sensor used in this study 
has 100 µm-thick air cavity and diaphragm consisting of 250 nm Si/~1 µm SiO2. c, Photograph 
of bioresorbable and commercial ICT sensors implanted alongside a bioresorbable ICP sensor. d, 
Fabry-Perot resonance signals and temperatures collected while raising ICT by covering the rat’s 





Figure 3.8 Bioresorbable optical pressure sensor based on photonic crystal (PC) microcavities. a, 
Schematic illustration of the device structures, indicating an array of PC cavities in the 
diaphragm. b, Scanning electron microscopic (SEM) image of the cavities fabricated on a 
silicon-on-insulator wafer, prior to wafer bonding and back-etching of Si wafer. c, Photograph of 
the diaphragm region. d, Optical spectrum from reflected laser (top), indicating red shift of the 
peaks with increasing pressure in highly linear fashion (bottom). e, Experimental set-up for 






Figure 3.9 Dissolution of bioresorbable optical pressure sensor. a) Schematic illustration of the 
dissolution experiment set-up. b) Optical micrographs of  bioresorbable optical pressure sensor at 





Figure 3.10 Dissolution of silicon photonic crystal microcavities fabricated on SOI wafer in 
phosphate buffered saline (PBS, pH ~7.4). a, Scanning electron microscopy (SEM) images of the 
device before (left) and after (right) dissolution in PBS at 85oC for 30 minutes. b, Blue shift of 
the optical spectrum with decrease in thickness of the silicon nanomembrane (left). Peak shift 
and silicon nanomembrane thickness as functions of time (right). 
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CHAPTER 4: PERSPECTIVE 
 
4.1 Summary 
Recent literature highlights bioresorbable implantable device technology, as a subset of a 
larger field known as ‘Transient electronics’, for which all of the constituent materials dissolve 
in biofluids at controlled rates to form biologically benign end products. Bioresorbable devices 
can reduce costs, patient distress, and risks of complication associated with surgical elimination 
procedures after useful timeframe, and they also minimize chances of infection or immune-
mediated tissue reactions, all of which are associated with conventional standard permanent 
hardware. In this study we demonstrated materials, device structures, fabrication approaches, and 
encapsulation strategies for bioresorbable intracranial pressure sensors for treatment of traumatic 
brain injury or hydrocephalus. Our results on in vivo biodistribution and biodegradability of the 
devices, as well as in vitro and in vivo demonstrations of their use in monitoring of intracranial 
pressure highlight the key features and capabilities. We also proposed optical pressure sensors 
based on principles of Fabry-Perot interferometry as next type of bioresorbable implant that can 
avoid issues of MRI compatibility and damage due to normal or leakage current flow, which are 
inherent to implantable electronic sensors. 
 
4.2 On-going/Future Work  
Currently we continue to build on bioresorbable optical sensor research, to develop a 
fully bioresorbable optical pressure sensing systems by fabricating bioresorbable optical 
waveguides and fibers based on silicon nanomembranes or PLGA to replace the commercial 




Bioresorbable Silicon Optical Waveguides 
Schematic illustration of fabrication process of bioresorbable silicon optical waveguides 
appears in Figure 4.1. The process begins with photolithography on SOI substrates (top Si ~200 
nm, buried oxide ~1 μm, Si wafer ~500 μm; SOITEC, France) using a MA/BA6 mask and bond 
aligner (SUSS MicroTec AG) (Fig. 4.1a) and positive photoresist AZ5214 (thickness 1.6 μm, 
Microchem). Subsequently, reactive ion etching process (Plasma-Therm RIE) removes the top 
silicon layer in regions not protected by the photoresist. Immersion in hydrofluoric acid (HF, 
49%; J.T. Baker, Inc, USA) for 2 min partially undercuts the buried oxide layer (Fig. 4.1b). Spin-
coating a layer of positive photoresist (PR, S1813, MicroChem Corp., spin condition: 4000 rpm 
with ramp 500 rpm/s for 30 s), flood exposing to ultraviolet light (10 mW/cm2 for 12 s) followed 
by immersion in a developer (MF319, MicroChem, for 30 s) removes the PR everywhere except 
beneath the m-Si at the perimeter, partially undercut regions (Fig. 4.1c). The residual PR serves 
as anchor to tether the m-Si structure to the underlying substrate during the subsequent 
immersion into HF for 3 hours to fully undercut the m-Si (Fig. 4.1d).  
A PDMS stamp allows retrieval of the m-Si structure from the source substrate, in a 
manner that exposed the backside to allow removal of residual photoresist by immersion in 
acetone. The PDMS stamp enables delivery of the m-Si onto a poly(lactic-co-glycolic acid) 
(PLGA) layer heated at 55oC on a hotplate (Fig. 4.1e). This PLGA layer (10 μm thick) forms 
from slowly drying a solution of this material onto a hydrophobic surface prepared by immersion 
of a Si wafer into 5 vol% trimethoxymethylsilane in hexane for 30 min followed by rinsing with 
DI water. Another layer of PLGA (10 μm thick) laminated on top and then annealed by exposure 
to ethyl acetate vapor for 30 minutes (Fig. 3.2f) enables bonding to the underlying PLGA, 
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thereby encapsulating the m-Si waveguide. Finally, a laser milling process defines strips of 
PLGA with widths of 1 mm and the m-Si in the center.  
Figure 4.2 illustrate a hybrid integration of silicon nanomembranes (Si NMs) with other 
organic and inorganic bioresorbable materials, which offers high performance, flexible electronic 
and photonic systems with proven biocompatibility and clinically relevant modes of operation, as 
an emerging type of biomedical implants that disappear, without risk to the patient, after a 
relevant operational time period. The technology of bioresorbable waveguides relies on methods 
including wafer-based microfabrication, transfer printing and polymer processing, for forming 
long, thin filamentary structures of monocrystalline Si from patterns in Si NM design to unfurl 
from dense, planar coiled layouts (Figs. 4.2a and b).  The addition of a bioresorbable polymer as 
a cladding layer, offers extended, mechanically flexible, bioresorbable waveguides with 
extremely low propagation losses even when embedded in biological tissues. Figure 4.2c shows 
an image taken by infrared camera, which reveals near-infrared light (wavelength: 1550 nm) 
propagating through a waveguide (thickness 1.5 µm, width 50 µm).  
Figure 4.3 shows photos and changes in intensity of transmitted light through silicon 
optical waveguide with PLGA cladding immersed in PBS at 70oC, indicating complete 
dissolution within 10 days and linear decrease in light intensity throughout the dissolution 
process.  
 
Biopolymer Optical Fiber 
Bioresorbable optical fibers can form from biopolymers such as poly(D,L-lactide-co-
glycolide) (PLGA) and poly(L-lactic acid) (PLA), which offer wide usage in conventional 
implantable devices and injectable products including bioresorbable sutures. Fabrication of 
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PLGA optical fibers is based on a thermal drawing process, which involves melting PLGA 
polymer crystalline powders at about 220°C, drawing out as fibers, and cooling down soft 
polymer fibers to allow crystalline-to-amorphous phase transition. Manipulation of drawing 
speed controls fiber diameters, optimized at about 220 µm for connection with standard optical 
measurement setups for biological research.  
Figure 4.4 shows a photograph of a PLGA optical fiber with about 220 µm diameter. The 
cylindrical fiber structure serves as a waveguide with guided photons undergoing total internal 
reflection at interfaces between the PLLA polymer (refractive index n = 1.47 and transparent in 
the visible ranges) and outer media, such as air (n = 1.0), dermal tissues (n = 1.38–1.44), and 
brain tissues (n = 1.36–1.42). The 220 µm diameter Bioers can be coupled with ceramic ferrules 
and linked to external laser and/or light-emitting diode (LED)-based light sources. Figure 4.5 
shows process of dissolution for PLGA optical fiber, with working time of around 2 days and 
full dissolution time of around 3 weeks.  
 
Integration with Pressure Sensor 
The next step in the development of a fully bioresorbable, optical sensing system 
involves integration of bioresorbable optical waveguides and fibers with pressure sensors. These 
efforts may require development of grating couplers to enhance transmission efficiency at the 
fiber-sensor interface, and use of bioresorbable polymers as adhesives to hold them together 
throughout their use. We’re also searching for ways to realize wireless pressure monitoring, by 
improving the design of optical sensors to be less sensitive to incident angle of laser, which if 
possible would greatly enhance their applicability. A proposed future direction for electronic 
sensors include development of fully wireless sensing schemes, enabled by use of passive RF 
132 
 
circuits, and applying these platforms in other biological spaces such as the eye to demonstrate 





Figure 4.1 Schematic illustrations and colorized SEM images of the steps for fabricating flexible 
silicon transient optical waveguides. a, Photolithography and reactive ion etching define Si 
filamentary waveguides from the Si device layer (200 nm thick) of a silicon-on-insulator 
substrate. b, Controlled etching using hydrofluoric acid consumes the exposed buried oxide 
(BOX) layer and partially undercuts the BOX layer underneath the edges of the waveguides. c, 
Spin coating a positive photoresist (PR), flood exposing and inserting the substrate into a 
developer leaves a thin strip of PR underneath the edges of the waveguides. d, Further etching 
removes the remaining BOX layer, thereby leaving the waveguides supported only by the PR 
structures. e, A PDMS stamp allows retrieval of the waveguides and exposure of their back sides 
such that immersion in acetone eliminates any residual PR. Physical transfer integrates the 
waveguides onto a layer of PLGA. f, Lamination of another layer of PLGA on top and exposure 
to solvent vapors of ethyl acetate seals the PLGA layers to thereby encapsulate the waveguide. 
g,h, Optical images of a zigzag waveguide with 32 turning corners. The thickness, width and 
contour length of the Si core are 200 nm, 50 μm and 72.6 cm, respectively. i, j, Optical images of 
a spiral waveguide with base radius 1 mm, top radius 1 cm, and 20 turns. SEM images of (a)-(e) 
share the same scale bar. The colorized regions in the SEM images correspond to silicon (blue), 




Figure 4.2 Bioresorbable optical waveguide consisting of filamentary silicon nanomembrane as 
core and PLGA as cladding. a, Schematic illustration (left) and colored scanning electron 
microscope (SEM) image of the device. b, Photograph of waveguide in normal (left) and 
unfurled (right) states, demonstrating high flexibility. c, Infrared image indicating light 





Figure 4.3 Dissolution of bioresorbable silicon waveguides with PLGA cladding in PBS at 70oC. 
a, Photographs of the device indicating complete hydrolysis of silicon filaments within 10 days. 
b, Optical measurements of the waveguide through the dissolution process. P: measured output 





Figure 4.4 Bioresorbable optical fiber made of poly(lactic-co-glycolic acid) (PLGA). Optical 
microscopy image of PLGA fiber (top). Light transmission through PLGA fiber at light 






Figure 4.5 Dissolution of bioresorbable PLGA optical fiber. a, Optical images of PLGA fiber at 
various stages of dissolution in phosphate-buffered saline (PBS, pH~7.4, 37 oC). b, Intensity of 
transmitted light through the PLGA fiber in PBS at 37oC. The transmission intensity decreases as 
the PLGA dissolves.  
 
